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Abstract 
Niina Lammi. Type 1 and Type 2 Diabetes among Young Adults in Finland. 
Incedence and Perinatal Exposures. National Institute for Health and Welfare (THL), 
Research 22. 144 pages. Helsinki, Finland 2009.  
ISBN 978-952-245-151-4 (printed), ISBN 978-952-245-152-1 (pdf)  
 
Diabetes mellitus is one of the major public health problems worldwide. Unlike the 
old terms juvenile-onset and adult-onset diabetes suggest, both type 1 diabetes 
(T1DM) and type 2 diabetes (T2DM) can be diagnosed at any age. However, the 
epidemiology of young adult-onset T1DM and T2DM among Finns is unknown. In 
addition, the recently implicated risk factors for T1DM and T2DM related to body 
size at birth and childhood growth need to be studied among young adults. This 
study aimed to examine the incidence of young adult-onset T1DM and T2DM 
among Finns, and to explore the possible risk factors for young adult-onset T1DM 
and T2DM that occur during the perinatal period and childhood.  
 
In the first two studies (I-II), the incidence of young adult-onset diabetes was 
examined among 15-39-year-old Finns during the years 1992-2001. Information on 
the new diagnoses of diabetes was collected from four sources: standardized 
national reports filled in by diabetes nurses, the Hospital Discharge Register 
(National Development Centre for Welfare and Health), the Drug Reimbursement 
Register, and the Drug Prescription Register (Social Insurance Institute). The type of 
diabetes was assigned using information obtained from these four data sources, and 
when necessary, medical statements were reviewed in order to confirm the 
diagnosis. The results showed that the incidence of T1DM among 15-39-year-old 
Finns was 18 per 100,000/year, and there was a clear male predominance in the 
incidence of T1DM. The incidence of T1DM increased on average 3.9% per year 
during 1992-2001. The incidence of T2DM among young Finnish adults was 13 per 
100,000/year, and it displayed an increase of as much as 4.3% per year during the 
study period. 
 
In the studies III-V, the effects of perinatal exposures and childhood growth on 
the risk for young adult-onset T1DM and T2DM were explored in a case-control 
setting. Individuals diagnosed with T1DM (n=1,388) and T2DM (n=1,121) during 
the period 1992-1996 were chosen as the diabetes cases for the study, and two 
controls matched by age, place of birth, and sex were chosen for each case from the 
National Population Register. Data on the study subjects’ parents and siblings 
(including date of birth) was obtained from the National Population Register. The 
study subjects’ original birth records and child welfare clinic records were traced 
nationwide. The results of the case-control study showed that the risk for young 
 THL – Research 22/2009 7 Type 1 and type 2 diabetes 
among young adults in Finland 
 
adult-onset T2DM was the lowest among the offspring of mothers aged about 30 
years, whereas the risk for T2DM increased towards younger and older maternal 
ages. Birth orders second to fourth were found protective of T2DM. In addition, the 
risk for T2DM was observed to decrease with increasing birth weight until 4.2 kg, 
after which the risk began to increase. In examining growth rate after birth, it was 
observed that a high body mass index (BMI) at the BMI rebound between ages 3-11 
years substantially increased the risk for T2DM, and the excess weight gain in 
individuals diagnosed with T2DM began in early childhood. Unlike in T2DM, 
maternal age, birth order, or body size at birth had no effect on the risk for young 
adult-onset T1DM. Instead, individuals with T1DM were observed to have a higher 
maximum BMI before the age of 3 than their control subjects.  
 
In conclusion, the increasing trend in the development of both T1DM and T2DM 
among young Finnish adults is alarming. The high risk for T1DM among the Finnish 
population extends to at least 40 years of age, and at least 200-300 young Finnish 
adults are diagnosed with T2DM every year. Growth during the fetal period and 
childhood notably affects the risk for T2DM. T2DM prevention should also target 
childhood obesity. Rapid growth during the first years of life may be a risk factor for 
late-onset T1DM.  
 
Information on the incidence of diabetes among young adults establishes a basis 
for future epidemiological research. A more profound understanding of the risk 
factors concerning T1DM and T2DM will aid more precise risk profiling and may 
lead to a better understanding of the pathogenesis.    
 
Keywords: birth order, birth weight, growth, incidence, maternal age, type 1 
diabetes, type 2 diabetes, young adults 
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Sokeritauti (diabetes mellitus) on yksi maailman vakavimmista 
kansanterveysongelmista. Toisin kuin entisistä termeistä nuoruusiän ja aikuisiän 
diabetes voisi päätellä, tyypin 1 diabetes ja tyypin 2 diabetes voivat puhjeta missä 
iässä tahansa. Sekä tyypin 1 diabeteksen että tyypin 2 diabeteksen epidemiologia 
suomalaisilla nuorilla aikuisilla on kuitenkin selvittämättä. Lisäksi viime aikoina 
esitettyjä syntymäkokoon ja lapsuuden kasvuun liittyviä riskitekijöitä tulisi tutkia 
myös nuorten aikuisten ikäryhmässä. Tämän tutkimuksen tavoitteena oli selvittää 
tyypin 1 ja tyypin 2 diabeteksen ilmaantuvuutta suomalaisilla nuorilla aikuisilla ja 
arvioida mahdollisia perinataalikaudella ja lapsuudessa esiintyviä nuorten aikuisten 
diabeteksen riskitekijöitä. 
 
Kahdessa ensimmäisessä osatyössä (I-II) tutkittiin tyypin 1 ja tyypin 2 
diabeteksen esiintyvyyttä 15-39-vuotiailla suomalaisilla vuosina 1992-2001. Tiedot 
uusista diabetestapauksista kerättiin diabeteshoitajien täyttämillä vakioiduilla 
lomakkeilla, sairaalapoistorekisteristä (STAKES), lääkekorvausrekisteristä 
(Kansaneläkelaitos) ja erityiskorvausoikeusrekisteristä (Kansaneläkelaitos). 
Diabeteksen tyyppi määritettiin käyttämällä diagnoosi- ja lääkitystietoja, ja tämän 
lisäksi tyyppi varmistettiin tarvittaessa lääkärinlausunnoista. Tulokset osoittivat, että 
tyypin 1 diabeteksen ilmaantuvuus suomalaisilla nuorilla aikuisilla oli 18 per 100 
000/vuosi, ja että tyypin 1 diabeteksen sairastuneissa oli selkeä miesenemmistö. 
Tyypin 1 diabeteksen ilmaantuvuus lisääntyi keskimäärin 3,9% vuodessa vuosina 
1992-2001. Tyypin 2 diabeteksen ilmaantuvuus suomalaisilla nuorilla aikuisilla oli 
13 per 100 000/vuosi ja tyypin 2 diabetes lisääntyi jopa 4,3% vuosittain tutkitulla 
ajanjaksolla.  
 
Osatöissä III-V selvitettiin perinataalisten tekijöiden ja lapsuuden kasvun 
vaikutuksia nuorten aikuisten tyypin 1 ja tyypin 2 diabeteksen ilmaantuvuuteen 
käyttäen tapaus-verrokki asetelmaa. Ajanjaksolla 1992-1996 diagnosoidut 1388 
tyypin 1 diabeetikkoa ja 1121 tyypin 2 diabeetikkoa valittiin diabetestapauksiksi, ja 
jokaiselle tapaukselle valittiin kaksi syntymäpäivän, sukupuolen ja syntymäpaikan 
suhteen kaltaistettua kontrollihenkilöä väestörekisteristä. Tiedot (sisältäen 
syntymäpäivät) tutkimushenkilöiden vanhemmista ja sisaruksista saatiin 
väestörekisteristä. Tutkimushenkilöiden alkuperäiset synnytyskertomukset ja 
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lastenneuvolakortit etsittiin arkistoista maanlaajuisesti. Tapaus-verrokkitutkimuksen 
tulokset osoittivat, että riski sairastua nuorena aikuisena tyypin 2 diabetekseen oli 
matalin noin 30-vuotiaiden äitien lapsilla ja taudin riski kasvoi äidin iän 
nuorentuessa tai vanhentuessa. Lisäksi perheen toisena, kolmantena tai neljäntenä 
syntyneillä lapsilla todettiin olevan pienempi riski sairastua tyypin 2 diabetekseen 
kuin esikoisella. Nuorten aikuisten tyypin 2 diabeteksen riski väheni syntymäpainon 
suurentuessa 4,2 kg asti, minkä jälkeen riski alkoi jälleen lisääntyä. Tutkimalla 
syntymänjälkeistä kasvua havaittiin, että korkea painoindeksi 3-11 vuoden iässä, 
hetkellä jolloin lapsen painoindeksi taittuu nousuun, lisäsi huomattavasti riskiä 
sairastua tyypin 2 diabetekseen nuorella aikuisiällä. Liiallinen painonnousu 
henkilöillä, jotka sairastuvat tyypin 2 diabetekseen, alkoi jo varhain lapsuusiässä. 
Toisin kuin tyypin 2 diabeteksessa äidin ikä, syntymäjärjestys tai syntymäkoko eivät 
vaikuttaneet riskiin sairastua tyypin 1 diabetekseen nuorella aikuisiällä. Sen sijaan 
henkilöillä, jotka sairastuivat tyypin 1 diabetekseen, painoindeksin huippu oli 
korkeampi alle 3-vuotiaana kuin heidän verrokeillaan.  
 
Yhteenvetona voidaan todeta, että sekä tyypin 1 että tyypin 2 diabeteksen 
ilmaantuvuuden nousu suomalaisilla nuorilla aikuisilla on hälyttävää. Suomalaisessa 
väestössä korkea riski sairastua tyypin 1 diabetekseen jatkuu ainakin 40 vuoden 
ikään, ja vähintään 200-300 suomalaista nuorta aikuista sairastuu tyypin 2 
diabetekseen vuosittain. Sekä sikiöaikainen että lapsuusiän kasvu vaikuttavat 
huomattavasti tyypin 2 diabeteksen riskiin. Tyypin 2 diabeteksen ehkäisemiseksi 
suunnitellut toimenpiteet tulisi ulottaa lapsuusiän lihavuuden ehkäisemiseen. Nopea 
kasvu ensimmäisinä elinvuosina saattaa olla nuorena aikuisena puhkeavan tyypin 1 
diabeteksen riskitekijä.  
 
Tieto nuorten aikuisten diabeteksen ilmaantuvuudesta luo pohjan tuleville 
epidemiologisille tutkimuksille. Yksityiskohtaisempi tieto tyypin 1 ja tyypin 2 
diabeteksen riskitekijöistä auttaa yksilöllisessä riskinarvioinnissa ja voi johtaa 
patogeneesin mekanismien tarkentumiseen.   
 
Avainsanat: ilmaantuvuus, kasvu, nuoret aikuiset, tyypin 1 diabetes, tyypin 2 
diabetes, syntymäjärjestys, syntymäpaino, äidin ikä   
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Diabetes mellitus är ett av de största hoten mot folkhälsan i världen. Tvärtemot vad 
de tidigare termerna ungdomsdiabetes och vuxendiabetes antyder kan typ 1-diabetes 
och typ 2-diabetes uppstå vid vilken ålder som helst. Dock är epidemiologin för 
både typ 1-diabetes och typ 2-diabetes hos finländska unga vuxna inte klarlagd. 
Dessutom bör riskfaktorerna, som enligt senaste rön har  samband med 
födelsevikten och tillväxten i barndomen, utredas även hos åldersgruppen unga 
vuxna. Syftet med denna studie är att klarlägga incidensen av typ 1-diabetes och typ 
2-diabetes hos finländska unga vuxna samt undersöka eventuella riskfaktorer för 
diabetes som förekommer under den perinatala perioden och i barndomen.  
 
I de två första delarbeten (I-II) undersöktes incidensen av typ 1-diabetes och typ 
2-diabetes hos 15-39-åriga finländare under åren 1992-2001. Uppgifterna om nya 
diabetesfall inhämtades från standardiserade formulär ifyllda av diabetessköterskor, 
sjukhusens utskrivningsregister (STAKES, Institutet för hälsa och välfärd), register 
över läkemedelsersättningar (Folkpensionsanstalten) och register över 
ersättningsgilla läkemedel (Folkpensionsanstalten). Typen av diabetes fastställdes 
med hjälp av ovannämnda källor och vid behov fastställdes diabetestypen med hjälp 
av information i läkarutlåtanden. Resultaten visade att incidensen av typ 1-diabetes 
hos finländska unga vuxna var 18 per 100 000/år och att av de som insjuknat i typ 1-
diabetes var majoriteten män. Under åren 1992-2001 ökade incidensen av typ 1-
diabetes i medeltal 3,9 % årligen. Incidensen av typ 2-diabetes hos finländska unga 
vuxna var 13 per 100 000/år och under tidsperioden för studien ökade incidensen av 
typ 2-diabetes så mycket som 4,3 % årligen.  
 
I delarbeten III-V undersöktes påverkan av perinatala faktorer och tillväxttid 
avseende incidensen av typ 1-diabetes och typ 2-diabetes hos unga vuxna genom att 
använda fall-kontrollstudier. Under tiden 1992-1996 valdes 1388 typ 1-diabetiker 
och 1121 typ 2-diabetiker som diabetesfall, och för varje diabetesfall valdes två 
kontrollpersoner ur folkbokföringsregistret matchade för födelsedatum, kön och 
födelseplats. Data (inklusive födelsedatum) avseende föräldrar och syskon till 
undersökningspersonerna inhämtades från folkbokföringsregistret. De ursprungliga 
födelsejournalerna och tillväxtkurvorna från barnavårdscentralen avseende 
undersökningspersoner inhämtades från arkiven i hela landet. Fall-kontrollstudiernas 
resultat visade att lägsta risken för att insjukna i typ 2-diabetes som ung vuxen hade 
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barn till cirka 30-åriga mödrar och risken ökade med moderns fallande eller stigande 
ålder. Dessutom konstaterades att barn nummer två, tre eller fyra i familjen löpte 
mindre risk att insjukna i typ 2-diabetes än förstfödda barnet. Risken för typ 2-
diabetes hos unga vuxna minskade vid födelsevikten upp till 4,2 kg varefter risken 
började åter öka. Vid studien av vikten efter födseln visade det sig att högt viktindex 
vid åldern 3-11 år, då barnets viktindex börjar stiga, väsentligt ökade risken att 
insjukna i typ 2-diabetes. Hos personer som insjuknade i typ 2-diabetes började 
övervikten framträda redan i tidiga barnaåren. I motsats till typ 2-diabetes påverkade 
inte moderns ålder, syskonordning eller födelsevikt för risken att insjukna i typ 1-
diabetes hos unga vuxna. Däremot var det maximala viktindexet vid tre års ålder 
högre hos personer med typ 1-diabetes än hos kontrollpersoner.  
 
Sammanfattningsvis kan konstateras att det är alarmerande att incidensen för 
både typ 1-diabetes och typ 2-diabetes ökar hos finländska unga vuxna. Inom den 
finländska befolkningen kvarstår den höga risken att insjukna i typ 1-diabetes 
åtminstone till 40 års ålder och minst 200-300 finländska unga vuxna insjuknar 
årligen i typ 2-diabetes. Tillväxten både under fostertiden och i barndomen påverkar 
väsentligt risken för typ 2-diabetes. För att stävja risken för typ 2-diabetes ska de  
förebyggande åtgärdena även inkludera barndomsfetma. Snabb tillväxt under de 
första levnadsåren kan vara en riskfaktor för insjuknande i typ 1-diabetes hos unga 
vuxna.  
 
Kunskap om diabetesincidens hos unga vuxna lägger grunden för de kommande 
epidemiologiska studierna. En genomgripande kunskap avseende riskfaktorerna för 
typ 1-diabetes och typ 2-diabetes är till gagn i den individuella riskbedömningen och 
kan leda till större förståelse för de patogeniska mekanismerna.  
 
Nyckelord: incidens, tillväxt, unga vuxna, typ 1-diabetes, typ 2-diabetes, 
syskonordning, födelsevikt, moderns ålder  
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1 Introduction 
Physicians face challenges when diagnosing diabetes among young adults. Type 1 
diabetes (T1DM) can be diagnosed at any age (1), and type 2 diabetes (T2DM) is 
becoming more prevalent among the young (2). Moreover, diabetes first presenting 
itself in young adulthood may prove to be something in between T1DM and T2DM 
(3, 4).     
 
Although new cases of T1DM diagnosed among children aged 0-15 years are 
registered in Finland, there are no registers of T1DM with onset after 15 years of 
age. In addition, T2DM with onset in adolescence or young adulthood is such a new 
phenomenon that its magnitude in Finland has not yet been determined. As a first 
step to understanding the specific characteristics of young adult-onset diabetes 
among Finns, the incidence of young adult-onset T1DM and T2DM has been 
examined in this study. It was possible to carry out this study in Finland for several 
reasons: the Finnish healthcare registers have proven to be comprehensive and 
highly reliable (5) and therefore they provide a useful tool for tracing new cases of 
diabetes. In addition, due to the world’s highest incidence of childhood-onset T1DM 
(6) and active educative projects on T2DM (7), Finnish healthcare can also identify 
these conditions among the more challenging young adult age group.   
   
In addition to basic epidemiology, risk factors for diabetes were also of interest 
in this study. It was discovered early that a deviation from the adopted growth curve 
during childhood may be the first sign of disease. Because of this, a close follow-up 
of growth has been a pertinent part of childhood health surveillance for decades, and 
the birth weights of newborn babies have been recorded for even longer. 
Fortunately, the documents including this data have been carefully archived in 
Finland, as if in anticipation of their new purpose that has been unveiled recently.  
 
The concept of ‘Developmental origins of health and disease’ (DOHaD), stating 
that chronic adult diseases result from adaptation to an adverse environment during 
development, emerged from the observations that body size at birth and childhood 
growth have a substantial effect on the future risk for T2DM and other chronic 
diseases (8). It has been shown that individuals born with low (or very high) birth 
weight (9), who grow slowly during their first years of life (10), and who experience 
early BMI rebound (11) have an increased risk for T2DM. Moreover, it has also 
been suggested that early growth has an effect on the risk for childhood-onset 
T1DM (12). According to studies conducted among individuals with childhood-
onset T1DM, individuals with T1DM seem to grow faster than their peers (12, 13). 
It is not known whether this also applies to cases of T1DM with onset after 15 years 
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of age. The second part of this study focused on the risk factors for young adult-
onset T1DM and T2DM that occur during the perinatal period and childhood.     
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2 Review of the literature 
2.1 Diagnosis and classification of diabetes mellitus 
2.1.1 Definition of diabetes mellitus  
 
Diabetes mellitus is defined as a group of metabolic disorders characterized by 
hyperglycemia. A diagnosis of diabetes is made by measuring the concentration of 
glucose from a venous plasma sample after 12 h of fasting, or by an oral glucose 
tolerance test (OGTT, where 75 g of glucose dissolved in water is consumed after 12 
h of fasting, and the plasma glucose concentration is measured at 2 h postload). The 
diagnostic criteria are met when the fasting plasma glucose concentration (FPG) is 
7.0 mmol/l, or if the 2-h postload glucose is 11.1 mmol/l during an OGTT (14, 
15) (American Diabetes Association (ADA) and World Health Organization (WHO) 
criteria). The glucose concentration can also be measured from a venous or capillary 
whole blood sample, in which case the diagnosis of diabetes is made at the glucose 
concentration of 6.1 mmol/l (fasting value) (16). According to the ADA definition, 
a diagnosis of diabetes can also be made if any casual plasma glucose measurement 
is 11.1 mmol/l and the person presents classic symptoms of diabetes (15). In 
Finland, the current diagnostic guidelines follow these international criteria (fasting 
plasma glucose 7 mmol/l, or 2-h postload glucose >11 mmol/l) (17). The current 
threshold FPG values are from 1997, when ADA tightened the criteria (18) (Table 
1). 
 
 
Table 1. Changes in the diagnostic criteria for diabetes 
 
Organization Fasting plasma 
glucose (mmol/l) 
2-h postload glucose 
(mmol/l) 
National Diabetes Data 
Group 1979 (19) 
7.8 11.1 
WHO 1985 (20) 7.8 11.1 
WHO 1999-2006  
(14, 16) 
7.0 11.1 
ADA 1997-2007  
(15, 18) 
7.0 11.1 
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The metabolic disturbances in diabetes mellitus are considerable. The absolute 
and/or relative insulin deficiency observed in diabetes causes defective glucose 
uptake in splanchnic and muscle tissues, and the glucose concentration in circulating 
blood rises. When blood glucose levels rise steadily above normal postprandial 
values (7-8 mmol/l), part of the excess glucose is excreted in the urine (the renal 
threshold for glucose is highly variable), and this osmotic diuresis results in the 
classic symptoms of diabetes: polyuria and polydipsia. Simultaneously, the release 
of free fatty acids (FFA) from the adipose tissue increases, and these FFAs are then 
utilized in energy metabolism instead of glucose. Together with glucosuria, this 
lipolysis results in involuntary weight loss. The inadequate concentration of insulin 
fails to suppress the secretion of glucagon (a counter-regulatory hormone for 
insulin), which further exacerbates hyperglycemia by enhancing gluconeogenesis 
(glucose production) and glycogenolysis (glucose release from the storage form 
glycogen) in the liver (21).  
 
The acute, severe complications of diabetes mellitus include ketoacidosis and 
hyperglycemic hyperosmolar states (21, 22). In addition, long-lasting hyperglycemia 
in poorly controlled diabetes promotes micro- and macroangiopathy, deterioration of 
the blood vessels, which manifests itself as general arteriosclerosis and 
cardiovascular disease, nephropathy, neuropathy and retinopathy (15, 23-25). These 
chronic complications are the major causes of morbidity and mortality associated 
with diabetes.  
2.1.2 Classification of diabetes mellitus 
 
The classification of diabetes mellitus has been under continuous revision (14, 15, 
19, 26). The previous classifications of diabetes were based either on age of onset 
(juvenile vs. adult-onset diabetes), or on the pharmacological treatment (insulin-
dependent diabetes mellitus vs. non-insulin-dependent diabetes mellitus) (19). The 
current ADA and WHO classifications of diabetes (14, 15) are based on the etiology 
and pathogenesis of diabetes mellitus, as this classification is found to be more 
appropriate for research purposes (26). Several etiopathogenetic subgroups can be 
identified among persons with diabetes mellitus.   
 
Type 1 diabetes 
In type 1 diabetes (T1DM), which accounts for 5-10% of those with diabetes,  
hyperglycemia results from an absolute deficiency of insulin caused by the 
destruction of insulin-secreting pancreatic -cells (15). The insulinopenia may be 
evidenced by low or undetectable concentrations of C-peptide (connecting peptide 
released with insulin in equimolar amounts) (21, 27), and patients with T1DM are 
dependent on exogenous insulin for survival. T1DM is further subdivided into two 
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entities: immune-mediated type 1A diabetes, where the destruction of -cells is 
caused by an autoimmune process, and idiopathic type 1B diabetes (only the 
minority of cases) with marked insulinopenia, but no evidence of autoimmunity 
(15).  
 
The etiology of T1DM is multifactorial. There is a significant genetic 
predisposition to T1DM, but the mode of inheritance is complex. The most 
important genes mediating the susceptibility to T1DM are located in the HLA-
region of the major histocompatibility complex in the short arm of chromosome 6 
(28, 29), where several predisposing and protective haplotypes have been identified. 
In addition, more than 20 other susceptibility regions have been implicated (28, 30). 
The T1DM pathogenesis cannot, however, be solely explained by heredity, as the 
concordance in monozygotic twins is only about 30% (31, 32), and the contribution 
of susceptibility genes to the incidence of T1DM appears to be decreasing with 
increasing incidence (33, 34).  
 
The pathogenesis of -cell destruction in immune-mediated T1DM is intricate. 
T-cell mediated immunity is considered to be essential in the pathogenesis, and 
autoreactive T-cells can be detected in the sera of patients with preclinical T1DM 
(35, 36). As a sign of autoimmunity, islet cell autoantibodies can be detected in the 
sera of patients with immune-mediated T1DM (islet cells refer to the islets of 
Langerhans in the pancreas, where the -cells are situated) (37-39). These islet cell 
autoantibodies are directed against glutamic acid decarboxylase (GAD, an enzyme 
present in pancreatic -cells) (38, 40), and protein tyrosine phosphatase (IA-2) (39) 
among others. In addition, antibodies to insulin (IAA) (41) have been reported. The 
occurrence of the autoantibodies in first-degree relatives of T1DM patients has been 
shown to predict T1DM (42). The current understanding is that unknown 
environmental factors trigger the autoimmune process leading to T1DM in 
genetically susceptible individuals.  
 
Type 2 diabetes 
Type 2 diabetes (T2DM), which is the most prevalent form of diabetes mellitus with 
90-95% of total cases, is characterized by insulin resistance and relative insulin 
deficiency (15). T2DM can be asymptomatic for several years before diagnosis, and 
a substantial proportion of patients with T2DM are undiagnosed and consequently 
without treatment (43, 44).  
 
The risk for T2DM rises with increasing age and is strongly associated with 
lifestyle factors such as obesity and physical inactivity (all risk factors are discussed 
in detail below). In individuals with abdominal obesity, the excess visceral adipose 
tissue promotes insulin resistance through the increased release of free fatty acids, 
hormones, and cytokines. The increased demand for insulin is exacerbated by the 
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possible lack of exercise. In the early stages of insulin resistance, pancreatic -cells 
can compensate for the increased demand for insulin, but over time, in individuals 
with susceptibility to T2DM, the -cells fail to compensate for the insulin resistance 
resulting in hyperglycemia (45).  
 
However, not all obese individuals develop T2DM. The genetic predisposition 
for T2DM is strong; the observed concordance rate in monozygotic twins is 50-76% 
(46, 47). The identification of the susceptibility genes for T2DM has been slow, 
because multiple genes with relatively modest effect sizes contribute to the 
individual’s risk (48). Candidate gene studies and the recent introduction of new 
molecular technologies have led to the identification of 11 susceptibility regions 
influencing the risk for T2DM (49-54). Because the genetic basis for T2DM is now 
starting to come to light, expectations are high that new information on the 
molecular pathogenesis of T2DM will be obtained in the near future.    
 
Other types of diabetes mellitus 
Besides T1DM and T2DM, the current classification recognizes additional 
subgroups of diabetes mellitus (14, 15). Gestational diabetes mellitus (GDM) is 
defined as glucose intolerance first discovered during pregnancy. GDM predicts a 
future risk for diabetes. Approximately 10% of Finnish women diagnosed with 
GDM developed diabetes during a 6-year follow-up; half of them developed T1DM 
and the other half developed T2DM (55). Moreover, the risk of developing T2DM 
rises to 25% in the next 15 years after the diagnosis of GDM (56). Diabetes mellitus 
can also be a consequence of genetic syndromes (such as Down’s syndrome or 
Prader-Willi syndrome), diseases of exocrine pancreas (such as pancreatitis), and 
endocrinopathies. Drugs (e.g. glucocorticoids) or chemicals can also induce 
diabetes. Maturity onset diabetes of the young (MODY) is a monogenic form of 
diabetes mellitus caused by single-gene defects affecting -cell function 
(abnormalities at six genetic loci have been identified) (15). MODY is inherited in 
an autosomal dominant pattern and manifests itself at a young age. The prevalence 
of MODY is unknown, but it is estimated to be a few percent of all patients with 
diabetes (57).   
2.1.3 Characteristics of diabetes in young adults 
 
In addition to the typical cases of T1DM and T2DM, the clinical manifestation of 
these types of diabetes can overlap substantially in young adults, thus making the 
classification intricate in this age group. Individuals with T1DM first diagnosed in 
young adulthood exhibit higher C-peptide values at diagnosis (27, 58, 59), slower 
disease progression (59, 60), and less high-risk genotypes (59-61) than children with 
a prepubertal diagnosis of T1DM. On the other hand, individuals with early-onset 
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T2DM can have characteristics of T1DM, as a considerable number of individuals 
diagnosed to have T2DM in adolescence have been demonstrated to be positive for 
islet autoantibodies (30% GAD positive and 35% IAA positive) (62). In the UK 
Prospective Diabetes Study, the percentage of patients with T2DM presenting GAD 
autoantibodies was negatively correlated with age at onset (34% in 24-35-year-olds 
vs. 7% in 55-60-year-olds) (63), and positive autoantibodies strongly predicted the 
need for insulin therapy during a 6-year follow-up period. A marked loss of -cell 
function has also been associated with early-onset T2DM (64). 
2.1.4 Intermediate type of diabetes 
 
Considering the overlap between the two major types of diabetes, it seems that a 
third type of diabetes, an intermediate type between T1DM and T2DM, may exist. 
Patients who are obese and insulin resistant with simultaneous markers of 
autoimmunity are often referred to as having the intermediate type of diabetes (3, 4, 
65), but this group is heterogeneous in its characteristics. Several names have been 
suggested for this intermediate type, such as type 1.5 diabetes (66) and double 
diabetes (4, 65), but the designation that has gained ground most is ‘latent 
autoimmune diabetes in adults’ (LADA) (67-70). Adult age at onset (>35 years), 
presence of circulating GAD antibodies, and absence of a requirement for insulin at 
diagnosis have been suggested as the criteria for LADA (68). However, the basis of 
this classification has been criticized (71), and it has been proposed that autoimmune 
diabetes is more of a continuum with T1DM and LADA at opposite ends rather than 
two separate entities (71, 72). In addition, the authors of a review summarizing 
clinical characteristics of LADA state that the epidemiological studies concerning 
LADA have produced conflicting results and propose that the continuum of diabetes 
types may also include T2DM (69). The latest clinical guidelines consistently direct 
physicians to treat diabetes according to clinical manifestation, and to put less 
emphasis on the assigned type of diabetes (17).  
 
Consensus criteria that would unequivocally separate the intermediate type or 
LADA from atypical phenotypes of T1DM or T2DM have not been defined. It has 
been suggested that instead of etiology, the future classification of diabetes should 
put emphasis on the common disease mechanisms leading to hyperglycemia (73).   
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2.2 Epidemiology of diabetes mellitus 
 
The ultimate goal of epidemiological research is to find causes that can explain 
disease occurrence (74). Thus, before examining the etiology of diabetes, the 
occurrence of diabetes must be examined. The occurrence of T1DM is commonly 
reported as the incidence rate (the occurrence of new cases per unit of person-time 
(74)), whereas the prevalence (the proportion of people in the population at risk who 
have the disease at a specific time (74)) is more often reported in studies of T2DM.   
2.2.1 Epidemiology of type 1 diabetes in children 
 
T1DM constitutes 5-10% of all cases of diabetes, and it is one of the most common 
chronic non-communicable diseases in children (21). The majority of knowledge on 
the epidemiology of T1DM is provided by studies investigating cases with onset 
before the age of 15 years. In the 1980s, the first international collaboration was 
initiated in order to obtain standardized data on the incidence of T1DM in children. 
The Diabetes Epidemiology Research International (DERI) was the first group to 
establish standardized population-based registries allowing comparison of the 
incidence of T1DM between countries (75). The DERI was followed by the 
EURODIAB ACE project, designed to investigate the variation of T1DM incidence 
in Europe (76, 77), and in 1990 WHO launched the Diabetes Mondiale 
(DIAMOND) project to expand this surveillance worldwide (6, 78). These large 
studies reported a remarkable geographical variation in the incidence levels of 
T1DM. The variation in incidence was over tenfold between the European 
populations in 1989-1998. The lowest incidence was observed in Macedonia (3.6 
per 100,000/year), and the highest incidence in Finland (43.9 per 100,000/year) (77). 
Globally, the variation in incidence exceeded 350-fold, when comparing Finland 
with China (0.1 per 100,000/year) during 1990-1999 (6). The studies investigating 
the geographical distribution of T1DM have consistently reported that the variation 
in incidence follows the distribution of ethnic groups; the highest rates of T1DM 
have been recorded in Europids (6, 79) and the lowest rates in the Asian populations 
(6, 78). Moreover, considerable intra-country variation has also been reported in 
genetically homogenous populations (80-82). Despite the efforts of the EURODIAB 
ACE and the DIAMOND projects, the incidence of T1DM remains unknown in 
many developing countries.   
 
According to the EURODIAB ACE and the DIAMOND studies, the incidence of 
T1DM was the lowest in the age group of 0-4-year-olds and thereafter increased 
with age reaching twofold incidence rates in 10-14-year-olds (6, 76). There were no 
significant differences in the incidence between genders (6). 
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The incidence of T1DM in children is increasing rapidly (6, 77, 83). In Europe, 
the average annual increase in the incidence during 1989-1998 was 3.2% (77), and 
the worldwide annual increase was 3.0% during 1960-1996 (83). In the DIAMOND 
study, the strongest increase in the incidence of T1DM was observed across areas 
with high or intermediate incidence (6). The increase was more rapid in the age 
group of 0-4-year-olds than in the older age groups (6, 77). Unfortunately, the 
standardized collection of data on the incidence of T1DM was discontinued within 
the framework of the DIAMOND study after 1999, which is why new information 
on worldwide incidence trends cannot be expected in the near future.   
 
The rapid rise in the incidence levels is considered to be one of the strongest 
arguments in favor of the environmental etiology of T1DM, because the increase is 
far too fast to be caused only by the natural selection of genes. However, in addition 
to the triggering environmental exposures, epigenetic factors may be one potential 
explanation for the increasing incidence of T1DM.  
 
In order to identify clues leading to possible environmental risk factors, the 
seasonality of the diagnosis of T1DM has been widely investigated. In several 
populations, lower incidence rates have been observed in the summer months (77, 
84, 85), but analogy, for example to the seasonal patterns of microbial infections, 
has not been confirmed (84, 85). It also seems that the seasonality of the diagnosis 
of T1DM may vary depending on the age at diagnosis (77, 84). A recent study based 
on worldwide DIAMOND data showed that the existence of a significant seasonal 
pattern correlated with a higher level of incidence (86).  
 
In Finland, the incidence of childhood-onset T1DM is increasing more rapidly 
than the worldwide average (87-89). The incidence was rising on average 3.4% 
annually between 1965-1996 (87) and even faster, on average 4.1% annually, 
between 1992-2005 (90). From 1997 to 2001, the incidence of T1DM in 0-14-year-
old Finns was 49.1 per 100,000/year (91), and there was a slight male predominance 
with a male/female ratio of 1.08 (92).    
2.2.2 Epidemiology of type 1 diabetes in adolescents and young adults 
 
Compared to the registers of childhood-onset T1DM, the collection of information 
on the incidence of T1DM in the population aged 15 years or older is less well 
organized and restricted to short observation periods. The incidence of T1DM in 
young adults is more difficult to estimate than in children, because other types of 
diabetes (T2DM, GDM, MODY, and secondary forms of diabetes) exist in young 
adults concomitantly, and a misclassification of the type of diabetes may occur 
especially when hyperglycemia is first diagnosed. In addition, as the onset of T1DM 
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in adults is often less acute than in children, all new cases are not necessarily 
hospitalized and might not end up in registers. Due to these difficulties, the case-
ascertainment rate in the studies on the incidence of T1DM in young adults is 
considerably lower than in studies on children, making comparison difficult.   
 
The studies investigating adolescent- and young adult-onset T1DM are reviewed 
in Table 2. In persons aged 15-19 years, the incidence of T1DM generally seems to 
be lower than in children (93, 94) and decreasing with age thereafter (93, 95-97). It 
is noteworthy that several studies on childhood-onset T1DM including the age group 
of 15-19 show that the peak in the incidence is during puberty (79, 82, 98-100), 
between 10 and 14 years, whereas in the post-pubertal age groups incidence is 
lower. The peak in the incidence of T1DM occurs earlier in females than in males 
following the timing of maturation (82, 101). The geographical variation in the 
incidence of T1DM among young adults is narrower than among children, and it 
seems that the decrease in incidence after the age of 15 is steeper in the high 
incidence areas, thus equalizing the incidence levels (102).  
 
Estimating the annual trend in T1DM incidence in young adults is challenging, 
because most of the studies cover only short periods. However, contrary to the 
increasing trend in childhood-onset T1DM, it has been suggested that the incidence 
after the age of 15 would remain stable (97, 103). Whilst marked sex differences in 
the incidence do not exist in children (6, 77), in adolescents and young adults, 
unexplained male predominance has been reported (82, 93, 94, 96, 97, 104, 105). In 
addition, there are few studies on the incidence of T1DM in young adults from the 
USA (98, 106) that report male excess in incidence similar to the European studies. 
Female excess has only been reported in New Zealand (107). 
 
The incidence of T1DM in Finnish adolescents was studied three decades ago 
between 1970-1979, when the incidence of T1DM in the age group of 15-19 years 
was found to be 24.1 per 100,000/year (82).   
 
 
 
 
 
 
 
 
      
 
Table 2.  Studies investigating the incidence of type 1 diabetes among young adults  
(Studies including individuals aged 15-29 years arranged by latitude) 
 
Authors Study area Age at dg Years Incidence/100,000/year   
(95% CI) 
M/F ratio Ascert. rate  
(%) 
Joner et al (104) Norway 15-29 1978-1982 17.0  na 87.8 
Blohme et al (96) Sweden 15-34 1983-1987 na 1.8 86 
Thunander et al (108) Kronoberg 
(Sweden) 
10-19          
20-29       
30-39 
1998-2001 29.4 (28.0-32.1)              
19.7 (18.0-21.7)              
11.7 (10.4-13.2)        
na 100 
Christau et al (101) Denmark 15-29 1970-1974 12.8 na na 
Ostrauskas et al (109) Lithuania 15-39 1991-1997 7.8 (7.3-8.4) 1.8 91 
Vandewalle et al (105) Antwerp (Belgium) 15-39 1989-1995 8.9 (7.8-10.2) 1.7 85 
Roglic et al (95) Zagreb (Croatia) 15-24     
25-34 
1988-1992 9.6 (7.1-12.7)           
6.5 (4.8-8.6) 
na 93-100 
Bruno et al (93) Turin (Italy) 15-29 1984-1988 5.8 (4.9-6.9) 1.8 93 
Allen et al (98) Dane 
La Crosse 
(Wisconsin, USA) 
15-29 1970-1979 10.6     
11.1 
na 75 
Goday et al (97) Catalonia (Spain) 15-29 1987-1990 9.9 (9.8-10.8) na 90.1 
Muntoni et al (94) Sardinia (Italy) 15-29 1989-1990 18.8 (15.9-21.7) na 92.4 
Kadiki et al (110) Benghazi (Libya) 15-34 1981-1990 11.9 (10.3-13.8) na >95 
 
na= not available 
26 
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2.2.3 Epidemiology of type 2 diabetes 
 
An overview of the prevalence of T2DM can be obtained from studies investigating 
the prevalence of all types of diabetes, as T2DM accounts for more than 90% of 
diabetes cases in most populations (21). The total amount of individuals with 
diabetes was assessed to be 246 million in 2007 (2), and an estimated 960,000 
deaths were caused by diabetes in 2001 (111). Moreover, the prevalence of T2DM is 
increasing rapidly (2, 112), and it has been predicted that the number of people with 
diabetes will rise to 380 million by 2025 (2). 
 
The worldwide T2DM epidemic is caused by the global transition from 
traditional to modern lifestyles, which often results in obesity and physical inactivity 
(113-115). In addition, demographic changes such as population growth, increase in 
life expectancy, and urbanization increase the number of diabetic subjects further (2, 
112). Taking into account the varying genetic susceptibility and the degree of 
changes in lifestyle between populations, it is evident that some populations are 
more severely affected than others. The estimated prevalence of diabetes for the year 
2000 in the population 20 years of age was 6.3% in developed countries (Europe, 
North America, Japan, Australia, and New Zealand), and 4.1% in developing 
countries (all others), and the predictions for the year 2030 were 8.4% and 6.0% 
respectively (116). In 2000, the highest prevalence of T2DM (>10% in the 
populations 20 years) was estimated to be in Greece, Malta, Qatar, the Arab 
Emirates, Nauru, Singapore, Mauritius, and Seychelles (116), whereas the countries 
having the highest number of cases were India, China and the USA (112). Among 
the ethnic groups that have undergone a prominent transition in lifestyle, extremely 
high prevalence rates have been reported: nearly 50% among 30-64-year-old Pima 
and Papago Indians of Arizona and 40% among Micronesian Nauruans (117). The 
profound effect of lifestyle transition is clear, as the prevalence of T2DM was 
observed to be less than one-fifth in the Mexican Pima Indians compared to the U.S. 
Pima Indians, whose common ancestry was proved by DNA testing (118). The 
lowest prevalence rates of T2DM are found in the rural areas of the least developed 
countries (2, 117).   
 
In developing countries, diabetes affects younger age groups than in developed 
countries, where the greatest increase in the prevalence is expected in the population 
over 65 years of age (112). The risk for T2DM and its major risk factor, obesity, are 
strongly linked to poverty and lower socio-economical status also in developing 
countries (113, 114, 119). The greatest increase in the prevalence of T2DM is 
estimated to occur in India, where the number of diabetic patients could reach 80 
million by 2030 (112).   
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The male/female (M/F) ratio in the prevalence of T2DM varies markedly among 
individual communities (117). In the younger age groups there is a slight male 
predominance, but in the older age groups there is a female excess (2, 112). 
Globally, the number of women with diabetes is greater due to their higher life 
expectancy. 
 
In a cross-sectional population-based survey conducted during 2004-2005, the 
prevalence of T2DM among 45-74-year-old Finns was 16% in women and 11% in 
men (120), which makes T2DM one of the most important public health problems in 
Finland.  
2.2.4 Type 2 diabetes among children and adolescents 
 
Even though the first report of pediatric patients with T2DM appeared in 1979 
(121), T2DM was rare in children and adolescents before the 1990s (122). When 
cases of T2DM first started to appear in children and adolescents, the problem was 
assumed to only concern ethnic minority groups on the North American continent. 
However, it was soon perceived that youth-onset T2DM was a worldwide 
phenomenon (2, 123-128). Although the epidemiological data on T2DM in children 
and adolescents is still very limited, it has been recognized that concomitantly with 
the rising prevalence of youth overweight, the incidence of early-onset T2DM is 
increasing (2, 122, 129, 130). The only report of a decreasing trend in the 21st 
century has been from Tokyo (131), where the prevalence of obesity also 
simultaneously decreased. The studies investigating the incidence of childhood and 
adolescent-onset T2DM are reviewed in Table 3.  
 
Ethnicity plays a significant role in the risk for T2DM with early onset, as the 
highest risk for childhood-onset T2DM is borne by indigenous populations (130). 
Youth-onset T2DM seems to be more prevalent in females than in males (132), 
which may be partially explained by the increasingly prevalent polycystic ovarian 
syndrome predisposing to T2DM (122). Young age does not protect patients with 
T2DM from complications, and early-onset T2DM can lead to morbidity or even 
mortality during the productive years of life (127). For example microalbuminuria 
(the earliest sign of diabetic nephropathy) has been reported to be more frequent in 
adolescents with T2DM than in those with T1DM (133). 
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Table 3. Studies investigating the incidence of type 2 diabetes among children 
and adolescents (arranged by study period) 
 
Authors Study 
area 
Age 
at dg 
Study 
years 
Incidence/100,000/year  
(95% CI) 
M/F 
ratio 
Ascert. 
rate (%) 
Lipton et al. 
(134) 
Hispanic 
and 
African-
American 
population 
of 
Chicago 
(the USA) 
0-17 1985-1994   3.2 (2.7-3.8) na 83-86 
Urakami et al. 
(126) 
Tokyo 
(Japan) 
6-12    
13-15
1974-2002 0.8 
6.4 
0.6     
0.9 
100 
Thunander et 
al. (108) 
Kronoberg 
(Sweden) 
0-9      
10-19  
1998-2001 0 
5.6 (4.9-6.9)                   
na 100 
Dabalea et al. 
(128) 
6.2% of 
population 
aged 0-19 
in the 
USA 
0-4      
5-9      
10-14  
15-19
2002-2003 
 
 
 
0 (0.0-0.2)                      
0.8 (0.5-1.2)                   
8.1 (7.1-9.2)               
11.8 (10.5-13.2)             
0.6 93 
na=not available 
 
Adolescent overweight has also been rapidly increasing in Finland. In 1977, the 
prevalence of overweight and obesity in Finnish adolescents aged 12-18 years was 
7.2% in males and 4.0% in females, but by 2003 the corresponding percentages were 
19% and 12% (135, 136). Moreover, the cardio-respiratory fitness of Finnish 
conscripts, as measured by the results of a 12-min running test, decreased by 12% 
(1979-2004) (137), and the prevalence of metabolic syndrome among Finnish 24-
year-old individuals increased from 1.0% in 1986 to 7.5% in 2001 (138). The 
number of Finnish adolescents and young adults with T2DM is unknown.     
 
After the recognition of the imminent T2DM epidemic among young individuals, 
both the International Diabetes Federation (IDF) and ADA have published 
consensus statements (130, 139) that urgently demand more research on the 
epidemiology, treatment, prevention, and outcome of youth-onset T2DM.    
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2.3 Risk factors for diabetes mellitus 
 
The confirmed and suggested risk factors for diabetes mellitus by clinical type are 
summarized in Table 4. 
 
Table 4. Risk factors for T1DM and T2DM  
 
  T1DM T2DM 
Confirmed  Genetic predisposition Genetic predisposition 
risk factors Young age Old age 
    Obesity, overweight, and central obesity 
Possible Micobial infections High intake of saturated fat (140) 
risk factors  Microbial toxins Low intake of dietary fibre (141) 
with evidence Vitamin D deficiency (142) Lack of exercise 
from at least High intake of nitrosamine-rich food (143) Cigarette smoking (144) 
three Early introduction of cow’s milk Decreased sleep duration (145) 
epidemiological High maternal age Low socio-economic status 
studies Caesarean section Birth size and early adiposity rebound 
  High birth weight Bottle feeding in infancy 
  Fast growth during childhood Low ground water magnesium (146) 
Risk factors without reference are discussed and cited in the main text.   
 
In T1DM, the autoimmune process leading to the destruction of the pancreatic -
cells is affected by environmental factors operating either as a trigger or an 
accelerator in the process. Several possible mediators, such as rate of growth in 
infancy (147), early nutrition (148), antenatal factors (149), viral infections (150), 
and bacterial toxins (151) among others (Table 4) have been proposed. However, a 
final consensus regarding their role in the pathogenesis of T1DM has not been 
reached thus far.  
 
Unlike the risk factors for T1DM, the concomitant occurrence of T2DM with 
obesity (body mass index (BMI) >30 kg/m2) is well documented (152, 153). 
Moreover, the location of the excess adipose tissue is of importance. Visceral fat 
accumulation has been shown to cause a higher risk for T2DM than subcutaneous 
adipose tissue (152), as the risk for T2DM rises with increasing waist circumference 
in individuals with a similar BMI (154). Among others (Table 4), a sedentary 
lifestyle has been suggested to be a risk factor for T2DM independent of obesity 
(155). In addition to lifestyle factors, the effects of fetal and childhood growth on the 
risk for T2DM have attracted increasing interest during the last 15 years (156).   
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The risk factors behind adult-onset T2DM seem to also apply to childhood- and 
adolescent-onset T2DM. There is evidence that a family history of T2DM, obesity, 
abdominal deposition of body fat, physical inactivity, and the effects of fetal growth 
are the main contributors (2, 122, 157).  
 
The possible risk factors for T1DM and T2DM related to the perinatal period, 
infancy, and childhood are reviewed in detail below. 
2.4 Early life risk factors for diabetes mellitus 
 
The onsets of both T1DM and T2DM are typically preceded by long subclinical 
periods, and it is therefore reasonable to search for possible causative environmental 
factors from many years before diagnosis. A vast number of epidemiological studies 
have aimed to find associations between perinatal conditions and the risk for 
diabetes.   
2.4.1 Parental attributes influencing the risk for type 1 diabetes 
 
Parental socio-economic status may contain potential non-genetic risk factors for 
T1DM, as it has a profound effect on many prenatal exposures such as health 
behaviors, living conditions, and nutrition. However, the association between socio-
economic status and the risk for T1DM remains unsettled. Both increased (158, 159) 
and decreased (160-162) incidence of T1DM have been associated with a higher 
socio-economic status, while the majority of studies report that there is no variation 
in incidence attributable to wealth (163-168). The conflicting results may be 
explained by the diverse definitions and classifications of socio-economic status 
examined in these studies, which vary from parental education to the gross domestic 
product of the country.  
 
Several studies have shown that the risk for childhood-onset T1DM rises with 
increasing maternal age (165, 168-173). It has been suggested that factors related to 
high maternal age may influence the maturation of the immune system in the child 
(169), thus predisposing the child to T1DM. In addition, advanced maternal age 
increases the occurrence of hypertension during pregnancy, pre-eclampsia, 
gestational diabetes, and delivery by Caesarean section (174), which may indirectly 
modify the risk for T1DM. The reported elevations in the risk have been modest, 12-
13% per every 5-year increase in maternal age (168, 169).  
 
The effect of maternal age may vary according to the characteristics of the 
population. A British study including patients from the Oxfordshire area found no 
association between maternal age and the risk for T1DM (175), whereas a study 
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comparing two British areas only reported an association in Scotland, but not in 
Northern Ireland (176). In addition, studies with a more specific stratification of the 
study population have revealed that the effect of high maternal age may be uneven 
between different subgroups. The effect of maternal age may vary according to the 
sex of the offspring (177), birth order (149), or age at the diagnosis of T1DM (166). 
Most of the studies investigating the effect of maternal age have only included 
patients under the age of 16 at the time of diagnosis of T1DM. The only study also 
including individuals with young-adult onset T1DM found no association between 
maternal age and the risk for T1DM (178).    
 
While maternal age at delivery is normally documented in birth records, data on 
paternal age at conception is more difficult to obtain. The risk for selection bias is 
high, as in population-based datasets paternal age is more often missing for firstborn 
children, for children of younger mothers, and in lower socio-economical classes 
(169). In the Northern Ireland cohort, the risk for T1DM increased with advancing 
paternal age (169), whilst a large Norwegian study did not find this association 
(149).  
 
In addition to the age of the parents, the birth order of the child (i.e. parity of the 
mother) in relation to the risk for T1DM has also been of interest. Although most 
studies have taken the correlation between maternal age and birth order into account, 
the results have been conflicting. Several studies have not found any association 
between birth order and the risk for T1DM (166, 175, 178, 179). However, there are 
also studies reporting contradicting results of a decreasing (168-170) or increasing 
(172) risk for T1DM with increasing birth order. The complex interactions between 
maternal age and birth order may explain these conflicting results: in a population-
based cohort study, a decreasing risk for T1DM with increasing birth order was 
detected only among children of mothers aged under 30 (149).  
 
Caesarean section has also been reported to increase the individual’s risk for 
T1DM (165, 166, 176, 180). An increased rate of Caesarean sections in mothers 
with T1DM could explain this association, but the effect remained statistically 
significant in the studies that were controlled for maternal T1DM (165, 180). It has 
been suggested that the quality of the bacteria first encountered by the newborn 
(180) or the non-specific stress experienced during birth by Caesarean section (166) 
may explain this association. However, evidence of an increased risk attributed to 
Caesarean sections has not been found in all studies (172), and an increased risk for 
T1DM related to complicated vaginal delivery instead of a Caesarean section has 
also been reported (181). Other less studied possible risk factors for T1DM are 
mother-child blood group incompatibility (166, 172) and pre-eclampsia (165, 166, 
175), both of which may be associated with the maturation of the immune system in 
the offspring.    
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2.4.2 Parental risk factors for type 2 diabetes 
 
Low socio-economic status predisposes to T2DM (119), which is explained to a 
large extent by the variation in nutrition, physical activity, and other related health 
behaviors between socio-economic groups (119, 182). The increased risk for T2DM 
seems to be mediated mostly through increased adiposity (183) in deprived 
individuals.  
 
The effects of parental age and parity on the risk for T2DM have been only little 
studied. It is well acknowledged that the prevalence of gestational diabetes increases 
with advancing maternal age (174), and evidence is accumulating that gestational 
diabetes in the mother may increase the risk for T2DM in the offspring 
independently of genetic factors (184). In addition, parity of the mother influences 
some key perinatal exposures such as birth weight (185, 186) and would therefore be 
worth examining. A study conducted in the 1990s suggests that birth order after 
fourth may be a risk factor for T2DM (187), while a cohort-study examining the 
associations between birth weight, adult adiposity and perinatal exposures found no 
association between parity and the risk for T2DM (183). 
 
2.5 Fetal and childhood growth and the risk for diabetes 
2.5.1 General concepts of childhood growth 
 
The infancy, childhood, puberty (ICP)-model 
The vertical growth of an individual begins from conception and ends when the 
growth plates of the long bones close due to the effect of sex hormones in the end of 
puberty. According to Karlberg, childhood growth consists of three components: 
infancy, childhood, and puberty, which reflect the three different hormonal phases of 
the growth process, and can each be described by separate mathematical functions 
(ICP-model presented in Figure 1) (188).  
 
Fetal growth in utero is dependent on the genetic growth potential of the fetus, 
the placental supply of oxygen and nutrients, the maternal nutritional status, and 
several hormones of which insulin and insulin-like growth factors are the most 
critical (189). According to the ICP-model, the infancy growth period comprises 
both fetal growth and its postnatal continuation. This rapid growth period continues 
until the age of 1 year, decelerating thereafter, and ceasing at the age of 3-4 years 
(188). 
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Simultaneously with the infancy growth period, the childhood growth period 
begins at approximately 1 year of age and continues slowing down gradually until 
the individual is full-grown (188). The most important promoter for childhood 
growth is the normal secretion of the growth hormone that regulates the insulin-like 
growth hormone system postnatally. In addition to the growth hormone, adequate 
secretion of the thyroid hormone is a prerequisite for normal postnatal growth, while 
insulin is also an important regulator (190).  
 
The increasing activity of the gonads sets off the third growth period during 
puberty, when sex steroids initiate the final pubertal growth spurt before the same 
hormones cause the growth plates to close, thereby ending vertical growth (188). 
This period occurs earlier in females than in males, following the timing of 
maturation. The pubertal growth spurt overlaps with the end phase of the childhood 
growth period.  
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Figure 1. Three components of childhood growth according to Karlberg (188) 
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Anthropometric measurements in newborns and children 
During 1979-1983, the mean birth weight of Finnish males born at term (40 weeks 
of gestation) was 3,722 g and their mean length was 51.1 cm. The same values for 
females were 3,582 g and 50.2 cm respectively (191). The higher birth weight 
among male newborns is suggested to result from anabolic effects of testosterone, 
and the differences in birth weights between sexes are shown to be consistent across 
all ethnic groups (192). Birth weight generally increases with parity and is lowest in 
the firstborn child (185).  
 
Body mass index (BMI) is defined as body weight (in kilograms) divided by the 
square of height (in meters). While the BMI thresholds of normal weight for adults 
(18.5-25 kg/m2) (193) cannot be applied to children, BMI-for-age has been proven 
useful in predicting overweight also in the 2-19-year-old population (194). While the 
vertical growth of a child is always positive with advancing age, the BMI growth 
curve also adopts negative values, because it is dependent on the changing body 
proportions during growth. The BMI of a newborn typically varies from 12 to 16 
kg/m2. After the neonatal period, the BMI of a child normally increases reaching its 
peak at the age of 1-2 years. After that, the BMI starts to decrease, followed by the 
BMI rebound (the point at which the BMI begins to increase again) typically 
between ages 3-8 years (193). The normal BMI growth curve is illustrated in Figure 
2.   
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Figure 2. Change in BMI during growth. Average BMI values adopted from 
Centers for Disease Control and Prevention (195) 
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The ponderal index (PI, defined as the cube root of body weight times 100 divided 
by height in cm) is comparable to BMI in the evaluation of the relationship between 
weight and height, but it enables a more fair comparison of infants and children of 
different stature, which is why it is often used instead of BMI when evaluating 
children at birth (196).  
2.5.2 Fetal and childhood growth and the risk for type 1 diabetes 
 
In 2001, Wilkin introduced ‘the Accelerator hypothesis’ (197) proposing that T1DM 
and T2DM are essentially the same disorder and the difference between them is only 
in the tempo of -cell loss. According to the hypothesis, three accelerators operate to 
a different extent in individuals who will later develop diabetes: an intrinsic high 
rate of beta-cell apoptosis, insulin resistance, and beta-cell autoimmunity. The rapid 
weight gain among western populations especially increases the prevalence of 
insulin resistance, which according to the hypothesis, is the environmental factor 
causing the increasing incidence of both T1DM and T2DM. Closely related is ‘the 
Overload hypothesis’, stating that the overfeeding of children leads to accelerated 
growth that overloads beta-cells thereby causing an increased risk for T1DM (198).   
 
The association between body size and the risk for T1DM has already interested 
researchers before the introduction of the Accelerator hypothesis. Several studies 
have provided evidence that high birth weight may be a risk factor for T1DM (168, 
169, 172, 199, 200). In a Norwegian population-based cohort, the association 
between the incidence of T1DM and birth weight was almost linear (200). An 
elevated risk for T1DM with high birth weight has also been reported from Australia 
(168), and the UK (169), and a pooled analysis combining data from seven 
European areas found low birth weight to be protective from T1DM (172). 
However, there are several studies that report no association between the incidence 
of T1DM and birth weight (147, 167, 175, 201-203), birth length (167, 202), or 
ponderal index at birth (167). A study including individuals with both childhood-
onset and young adult-onset T1DM reported a significant association between high 
birth weight and the risk for T1DM only among those who were diagnosed before 
10 years of age, and not among the later-onset cases (204).   
 
The mechanisms by which birth weight may modify the risk for T1DM are 
unknown. To make the matter more complex, it was recently reported that the 
required dose of insulin was in fact lower in children with T1DM born with high 
birth weight, and the authors suggested that birth weight may be a determinant of 
insulin resistance in T1DM (205). Moreover, children diagnosed with T1DM 
between the ages 0-4 years weighed significantly less at birth than those who 
developed diabetes later (147). On the other hand, it has been shown that the HLA 
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genotypes predisposing to T1DM are associated with rapid intrauterine growth 
resulting in high birth weight (206, 207). 
 
Most of the studies assessing an association between gestational age and the risk 
for T1DM have found no such association (175, 178, 200). A decreasing risk with 
increasing gestational age has been reported (168, 169), and one study found a small 
risk elevation in those born before 38 weeks of gestation (166). There are also 
reports of an increased risk in individuals born large for their gestational age (178, 
199), but this has not been confirmed in all studies (175).  
 
Although no conclusion on the role of birth weight or gestational age in the 
etiology of T1DM has been made, there is strong evidence indicating that 
individuals who develop T1DM grow faster than their peers during infancy (12, 13, 
147, 208, 209). In the 1990s, it was observed that the weight gain from birth to 6-30 
months of age was greater in children subsequently developing T1DM (147), and 
boys were taller prior to the diagnosis than their age-matched controls (208). 
Subsequently, a Finnish case-control study reported that children diagnosed with 
T1DM were heavier and taller than their controls throughout childhood (12). This 
finding was also later confirmed (13, 209). All these studies were conducted among 
individuals who were younger than 15 years of age when diagnosed with T1DM.  
 
The fast growth among children with T1DM may be caused either by genetic 
factors or infant nutrition. A reduced risk for T1DM among breastfed children has 
been observed (13, 210). Moreover, it has also been reported that breastfed children 
gain less weight than bottle fed children, and it has been suggested that this may 
explain the protective effect of breastfeeding (147). On the other hand, bottle 
feeding with cow’s milk formula may be a risk factor independently of childhood 
growth, as the increased risk for T1DM in children with early bottle feeding 
remained after adjustment for their individual weight gain curves (201).  
 
In support of the Accelerator hypothesis, it has been reported that the BMI of an 
individual and the age of onset of T1DM are inversely correlated (211-214), but all 
studies have not been able to confirm this correlation (215, 216). Estimating the 
possible associations between BMI and T1DM onset is difficult, however, as 
involuntary weight loss is one of the major symptoms of T1DM. The only study also 
including individuals with young adult-onset T1DM found no association between 
an individual’s BMI and age of T1DM onset (217). Although there is some evidence 
supporting the Accelerator hypothesis, it has remained controversial (218).  
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2.5.3 Risk factors for type 2 diabetes related to fetal growth and growth 
during infancy 
 
Twenty years ago, Barker and his colleagues showed in a Hertfordshire cohort that 
mortality from coronary heart disease (CHD) fell with increasing birth weight (219). 
This observation led to the formation of ‘the fetal origins of adult disease 
hypothesis’, stating that chronic adult diseases result from fetal adaptation to an 
adverse environment during development (220). It was discovered later that the 
plastic phase of development is not restricted to the fetal period, and the hypothesis 
was expanded to ‘the developmental origins of health and disease (DOHaD)’ 
concept (8), with wide-ranging consequences on our knowledge of the early origins 
of chronic non-communicable diseases. 
 
The observation that CHD was associated with conditions in utero was rapidly 
applied to other related adult diseases. In 1991, Hales and Barker reported that the 
odds ratio to develop impaired glucose tolerance (IGT) or T2DM was 6.6 for men 
whose birth weight was 2.5 kg compared to those weighing >4.3 kg at birth (221). 
In addition, an inverse association between birth weight and the risk for metabolic 
syndrome was demonstrated in a cohort of 266 individuals from Preston by the same 
authors (222). Subsequently, the increased risk for T2DM in low birth weight 
individuals was confirmed in the USA (223, 224), Sweden (225, 226), and Finland 
(227) among others (228-230).  
 
However, a study conducted among Pima Indians in the USA indicated that the 
relationship between birth weight and a subsequent risk for IGT and T2DM was not 
linear but U-shaped (231). In this study, maternal diabetes during pregnancy was 
associated with an increased risk for IGT and T2DM among individuals with birth 
weight 4.5 kg. A similar relationship between birth weight and the risk for T2DM 
was observed among Taiwanese schoolchildren (232). Two recent reviews that have 
examined the relationship between birth weight and T2DM support these 
observations: the possible positive association at high birth weights could not be 
ruled out in the analysis by Whincup and colleagues (233), and the analysis by 
Harder and associates showed a U-shaped pattern (9).  
 
The risk for T2DM was also found to be associated with anthropometric 
measurements other than birth weight. As a marker of reduced fetal growth, both 
short birth length (227) and a low ponderal index (225, 227) have been reported to 
increase the risk for T2DM. In South India, an increased risk for T2DM was found 
among individuals with high ponderal indices and heavy mothers (234), representing 
the elevated risk in the macrosomic babies of glucose-intolerant mothers.   
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When an association between a possible exposure and subsequent disease is 
found by epidemiological methods, the first concern is to determine whether it is 
caused by confounding factors. Birth weight is to a large extent influenced by the 
length of gestation. Many studies examining the association between birth weight 
and the risk for T2DM did not record gestational age (221, 223, 229, 235), but those 
who controlled for gestational age did not find significant changes in results 
compared with crude birth weights (224, 236). Two studies reported that gestational 
age was not associated with the risk for T2DM (227, 232), while one study found a 
slight increase in the risk for T2DM for preterm babies (228). It has also been 
debated whether the studies examining the effect of birth weight should be adjusted 
for adult BMI (237). Lucas and colleagues even argue that some reported 
associations between birth size and T2DM may result from careless adjustment for 
suspected confounding factors such as current body size (238). For example, an 
analysis aiming to explore the association between birth size and T2DM is actually 
exploring the effect of change in body size from birth to the present if the analysis is 
adjusted for current body size. In addition, birth size often correlates with current 
body size, which has to be taken into account when interpreting results. In most 
studies that have adjusted for adult body size, the risk elevation in low birth weight 
individuals has been independent of adult BMI (221, 223, 231) or waist 
circumference (229). An adverse adult or childhood environment represented by low 
socio-economic status does not seem to explain the risk conveyed by intrauterine 
growth retardation either (221, 227).  
 
Early studies investigating the association between early growth and T2DM 
already found an increased risk for T2DM in individuals who had low weight at 1 
year of age (221). Additional information on the effect of childhood growth was 
provided by studies examining two cohorts born in Helsinki (10, 11, 227, 239). 
These studies showed that the risk for T2DM was greatest in those who were small 
at birth (227), grew slowly until the age of 2 years (10), experienced an early 
adiposity rebound (11), and experienced accelerated growth between the ages of 7-
15 years (227). A large, prospectively followed cohort from South Delhi confirmed 
the results of the Helsinki cohort (236), and it was consistently reported from the 
UK that an early adiposity rebound (235) and rapid growth of the BMI in 
adolescence (230) increased the risk for T2DM.  
 
The most important environmental determinant of early infant growth is 
appropriate nutrition. A systematic review of studies investigating the effect of 
breastfeeding on the risk for T2DM suggested a reduced risk for breastfed children 
compared to those who received formula (240).    
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Figure 3. Suggested mechanisms for the association between birth size and type 
2 diabetes 
 
The observed association between low birth weight and the risk for T2DM has 
elicited several explanations (Figure 3). The fetal origins hypothesis (220)  suggests 
that in response to inadequate oxygen and nutrient supply in utero, the fetus 
undergoes metabolic adaptations, such as enhanced glucose supply to the vital 
organs at the expense of the muscle tissue, thereby improving survival. As a result, 
the fetus fails to achieve the birth weight determined by its genetic growth potential. 
However, once the plastic period of development is over, these adaptive changes 
cannot be reversed. Therefore, individuals who are permanently adapted to an 
efficient utilization of the available nutrition will have an increased susceptibility to 
obesity, insulin resistance, and CHD in an affluent adult environment. However, 
recent findings based on experiments on laboratory animals suggest that 
 
Small size at birth 
Excess nutrition and lack of exercise in extrauterine environment: 
Type 2 diabetes 
Fetal insulin 
hypothesis 
Fetal 
programming 
 
Maternal constraint: 
Small body size, poor nutritional status, age, diseases, 
placental dysfunction, smoking 
Genetic evolution:  
Deprivation 
experienced by 
previous generations 
Gene-
environment 
interaction 
Epigenetic 
changes 
Postnatal growth Early life 
conditions 
 THL – Research 22/2009 41 Type 1 and type 2 diabetes 
among young adults in Finland 
 
reprogramming may be possible during the late phase of developmental plasticity. In 
rat offspring with low birth weight, leptin treatment during the postnatal days 3-13 
reversed the metabolic changes caused by the malnutrition in utero (241).   
 
It is likely that growth trajectories during the fetal and early postnatal periods 
merely reflect the underlying adaptation process (fetal programming) and do not 
cause adult disease itself. Evidence from the Dutch famine showed that the 
incidence of CHD was highest in individuals whose mothers had been exposed to 
famine during early gestation, and this effect was independent of birth weight (242). 
It has also been reported that low birth weight and slow BMI growth during the first 
two years of life predict lower lean mass and a higher body fat percentage in 
adulthood (243, 244), thereby increasing the risk for T2DM independently of the 
absolute attained BMI. A tendency to a sedentary lifestyle may also be programmed 
prenatally: an experiment with rats showed that low birth weight offspring of 
undernourished rats were significantly less active than those born with normal birth 
weight (245).  
 
In addition to the concept of fetal programming, it has been suggested that the 
association between low birth weight and susceptibility to T2DM is caused by a 
genetic predisposition to both of them. ‘The fetal insulin hypothesis’ states that 
genetically determined insulin resistance in the fetus causes impaired insulin-
mediated growth in utero, resulting in low birth weight and an increased risk for 
T2DM in adulthood (246). Additionally, it has been suggested that birth weight is 
lower than average among offspring of diabetic fathers (247), and there is evidence 
that susceptibility alleles for T2DM may affect birth weight (248). However, the 
fetal insulin hypothesis does not explain for example the results of the Helsinki 
Study of Very Low Birth Weight Adults (249), which showed that among young 
adults born prematurely with a birth weight of less than 1,500 g, there were no 
differences in insulin resistance between individuals born small for gestational age 
(SGA) and individuals born appropriate for gestational age (AGA). Instead, when 
compared to young adults born at term with normal birth weight, young adults (both 
SGA and AGA) who were born at less than 1,500 g were significantly more insulin 
resistant.  
 
There is increasing evidence that epigenetic changes (changes in gene expression 
that are stable between cell divisions, but do not involve changes in the underlying 
DNA sequence) may have a role in the early programming of adult disease. One of 
the mechanisms of epigenetic modification is DNA methylation, which affects the 
regulation of gene expression. Wolff and his colleagues reported a link between 
maternal diet, DNA methylation, and the phenotype of the offspring in mice: feeding 
a methyl-supplemented diet to pregnant mice altered the epigenetic gene regulation 
and phenotype in their offspring (250).  
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It is also possible that gene-environment interactions play a role in determining 
an individual’s risk for T2DM (251). It has been reported that the association 
between small body size at birth and insulin resistance was apparent only among 
individuals who were carriers of the high-risk allele of the PPAR- gene (52, 252), 
indicating that the effect of genotype was modified by intrauterine growth 
retardation.  
 
While several possible mechanisms behind the association between low birth 
weight and T2DM are still being considered, expectations are high that a more 
profound understanding of the underlying mechanisms leading to T2DM will 
provide new means for primary prevention. However, while fetal and childhood 
growth may have a marked effect on the future risk for T2DM, the importance of 
lifestyle factors in the pathogenesis of T2DM should not be underestimated. 
Regardless of the conditions during the fetal period and early infancy, the risk for 
T2DM can be substantially reduced by lifestyle interventions among high risk 
individuals (253).  
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3 Aims of the study 
The aims of the study were to examine the incidence of T1DM and T2DM among 
young Finnish adults aged 15-39 years, and to determine the effects of prenatal and 
infancy exposures on the risk for young adult-onset T1DM and T2DM.  
 
The specific aims of the study were:  
 
• To determine the ten-year (1992-2001) incidence of T1DM and T2DM among 
young Finnish adults with special emphasis on the annual variation in incidence 
(Papers I-II). 
 
• To study the effects of perinatal exposures such as parental age, birth order, birth 
weight, gestational age, placental weight, and maternal body size on the risk for 
young adult-onset T1DM and T2DM (Papers III-IV). 
 
• To assess the effect of BMI growth trajectories on the risk for young adult-onset 
T1DM and T2DM (Paper V). 
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4 Materials and methods 
4.1 Study subjects 
 
Papers I-II  
Information on new diagnoses of diabetes was collected among people aged 15-39 
years who were resident in Finland and diagnosed between January 1st 1992 and 
December 31st 2001. Data for this register-based study were obtained from four 
different sources:  
 
1. During the years 1992-1996, new cases of diabetes were reported to the 
Diabetes and Genetic Epidemiology Unit of the National Public Health 
Institute using standardized forms (later SF) filled in by diabetes nurses 
in hospitals and primary care diabetic clinics in Finland. The date of 
diagnosis of diabetes and the date of the start of insulin treatment were 
included in the forms. 
 
2. The Finnish National Hospital Discharge Register (HDR), maintained 
by the National Research and Development Centre for Welfare and 
Health (STAKES), includes up to four hospital discharge diagnoses of 
patients who have been admitted to a hospital ward. The treating 
physicians assign the diagnostic codes using the International 
Classification of Diseases (ICD-9 until 1995 and ICD-10 from 1996 
onwards). The Finnish version of ICD-9 also includes information about 
the type of diabetes (see Appendix 1 for the codes). The diagnoses made 
in hospitals were based on clinical characteristics, C-peptide 
measurements and, in part of the cases, glutamic acid decarboxylase 
(GAD) antibody measurements. 
 
3. Since late 1994, all Finnish prescriptions have been included in the Drug 
Prescription Register (DPR) of the Social Insurance Institute (SII). 
Prescriptions searched for were all the class A10 drugs in the WHO 
Anatomical-Therapeutic-Chemical Classification System (drugs used in 
diabetes; insulin and analogues, blood glucose lowering drugs, other 
drugs used in diabetes) (254). 
 
4. The Drug Reimbursement Register (DRR) of the Social Insurance 
Institute comprises information on persons entitled to free-of-charge 
medication for diabetes. Glucose-lowering agents (insulin and oral 
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medication) prescribed by a physician are free-of-charge in Finland and 
are subject to the approval of a physician of the Social Insurance 
Institute, who reviews each case history. Patients who apply for free-of-
charge medication must attach a detailed medical statement prepared by 
the treating physician, who provides data to confirm the diagnosis of 
diabetes. Individuals with T2DM are only entitled to free-of-charge 
medication after a 6 month period of lifestyle intervention, which is why 
these medical statements also include details about the type of diabetes, 
clinical characteristics, and treatment. However, the DRR records only 
include information on the diagnosis of diabetes, but not the type of 
diabetes. Individuals with GDM are not entitled to free-of-charge 
medication unless the need for glucose-lowering medication continues 
after delivery. 
 
The data obtained from registries were linked using the unique personal 
identification number assigned to every Finnish resident. The date of diagnosis was 
set as the date of the first entry in one of the registers.  
 
All individuals who had any diabetes-related information from at least two data 
sources were included in the data at the beginning of the study. Cases with apparent 
gestational diabetes and secondary forms of diabetes were then excluded from the 
data if they fulfilled the following criteria:   
 
• Gestational diabetes: female sex, only diagnoses of GDM in the HDR (ICD-
codes 6480A, 6488A, O24.4, and O24.9), no entitlement to free-of-charge 
medication, no purchases of oral glucose-lowering agents 
 
• Diabetes secondary to other diseases: diagnosis of certain genetic syndromes, 
diseases of exocrine pancreas, or endocrinopathies prior to the diagnosis of 
diabetes mellitus in the HDR (ICD-codes: 5770, 5771, 5779, 0723A, 157, 2530A, 
2550A, 2750, 2751, 2770A, 5710-5713, 7517A, 7580A, 8680A, 2513A, K85, 
K86, K86.3, K87.1, K90.3, B26.3, C25, E22.0, E24, E31.00, E83.1, E83.0, E84. 
K70, Q45.0-Q45.3, Q90, S36.2, and E89.1) 
 
The remaining cases were classified as T1DM, T2DM or an undefined type of 
diabetes. The classification criterion was a consistent diagnosis from at least two 
data sources. The information from the four data sources was used in the 
classification as follows:   
 
• First insulin administration on the day of diagnosis (while not pregnant) 
according to the standardized form was counted as a reference to T1DM. 
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• Diagnoses with ICD-codes 2500B-2508B, E10.0-E10.9, and O24.0 in the HDR 
were counted as a reference to T1DM. 
 
• Insulin administration immediately at the diagnosis and continued until the end 
of the available information on the DPR (the end of the year 2004) was counted 
as a reference to T1DM.  
 
• Diagnoses 2500A-2508A, E11.0-E11.9, and O24.1 in the HDR were counted as a 
reference to T2DM. 
 
• Only temporary entitlement to free-of-charge medication was counted as one 
source referring to T2DM, because in T1DM permanent entitlement is admitted 
at the diagnosis.  
 
• Treatment with only oral glucose-lowering agents was counted as a reference to 
T2DM.  
 
• Diagnoses 2500C, 2500X, E12, E13, E14, G59.0, G63.2, G73.0, G99.0, H28.0, 
H36.0, I79.2, M14.6, N08.3, O24.2, O24.3, P70, and R73 did not allow 
conclusions as to the type of diabetes.  
 
• When insulin was first administered years after the diagnosis, this information 
did not allow conclusions as to the type of diabetes, as the onset of T1DM may 
be slow in young adults and T2DM may require insulin during the natural course 
of the disease.  
 
Cases with equivocal information on the type of diabetes (no two sources 
consistently referring to T1DM or T2DM) were further scrutinized. For these 
individuals, the original applications for free-of-charge medication were obtained 
from the SII (n=1,428). The records were reviewed by a physician (N.L.). Based on 
the clinical characteristics and treatment reported in the applications, the type of 
diabetes was assigned according to the 2006 criteria of ADA (255). Information 
available on the unclear cases who had not applied for free-of-charge medication 
was reviewed and classified. Most of these cases were found to have gestational 
diabetes (diagnosis of childbirth in the HDR within 6 months of the record referring 
to diabetes, and no further records in the HDR or in the DPR) and they were 
excluded from the study.  
 
A total of 8,547 cases were jointly ascertained from the four data sources. 
Women diagnosed with GDM (n=1,702) and patients with secondary forms of 
diabetes (n=347) were excluded. The remaining (6,491) cases were classified as 
T1DM (n=3,078), T2DM (n=2,392), and undefined diabetes (n=1,021). The group 
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of undefined diabetes cases included individuals with confirmed or suspected 
MODY or LADA and all individuals with inadequate information for classification. 
Data sources and classification are illustrated in Figure 4.  
 
 
 
 
 
 
 
 
 
 
    
 
 
 
 
 
 
 
Figure 4. Data sources and classification of the diabetes mellitus cases.  
SF= Standardized forms, HDR= Hospital Discharge Register, DPR= Drug 
Prescription Register, DRR= Drug Reimbursement Register 
 
 
 
 
 
 
 
 
Figure 5. Coverage of the data sources relative to the study period 
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Case ascertainment 
The capture-recapture method (256), often used in the assessment of the case-
ascertainment rate in register-based diabetes research, was not completely applicable 
to this study. A prerequisite for the capture-recapture method is that the data sources 
used need to be independent. In this study, the DPR, the DRR, and the HDR were 
not independent sources. Moreover, the coverage of these data sources was uneven 
(as illustrated in Figure 5). The second independent data source, SF, was only 
available for the first half of the study period. Standardized forms were efficient in 
detecting individuals with T2DM treated only with lifestyle intervention, as these 
individuals are not registered in the DPR or the DRR. Therefore, it can be assumed 
that the case-ascertainment rate was higher between the years 1992-1996 than 
between 1997-2001. When calculated with the capture-recapture method using the 
standardized forms as the primary data source and other sources combined as the 
secondary data source, the case-ascertainment rate between 1992-1996 was 88% for 
T1DM, T2DM, and undefined diabetes together (annual variation 88%-90%). Due 
to the lack of two independent data sources, it was not possible to calculate the case-
ascertainment rate for the years 1997-2001, but for the above mentioned reasons, it 
is likely to be somewhat lower.     
 
Papers III-V 
A case-control setting was formed in order to examine the associations between 
perinatal exposures, childhood growth and the risk for young adult-onset diabetes 
reported in papers III-V.  
 
Individuals with T1DM (n=1,388) and T2DM (n=1,121) diagnosed during 1992-
1996 (the first half of the study period), were chosen as the diabetes cases for the 
case-control study. Individuals with GDM, secondary diabetes, and undefined 
diabetes were excluded.  
 
Two non-diabetic control individuals matched by birth date, birth place, and sex 
were randomly chosen from the National Population Register for each diabetic 
subject. For 33 subjects with T1DM and 34 subjects with T2DM, only one control 
was found. The non-diabetic status of the control individuals was confirmed by 
computer linkage to the HDR, the DPR and the DRR.  
 
Data on the parents and the siblings of the study subjects, including their dates of 
birth, were obtained from the National Population Register.  
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4.2 Data on perinatal exposures and childhood growth 
 
Papers IV-V 
Birth records and child welfare clinic records were collected for cases and controls 
from hospital and health center archives and the archives of municipalities 
nationwide. The records were traced based on information on the place of birth, 
which was obtained from the National Population Register. 
 
Finnish birth records are filed under the name and birth date/personal 
identification number of the mother in the hospital where the delivery took place. In 
order to find the birth records, names and personal identification numbers of the 
mothers were obtained from the National Population Register. Because there was no 
specific information on the hospital where the study subject was born, birth records 
were searched from all hospitals (university, central and district hospitals) located in 
the same province as the municipality of birth. The birth records include information 
on maternal health during pregnancy, course of delivery, gestational age, and size of 
the newborn. 
 
The health and development of Finnish children aged 0-7 years are monitored in 
child welfare clinics, where children are taken to regular examinations performed by 
public health nurses and primary care physicians. From the age of 7 onwards these 
examinations are conducted by school healthcare until the end of compulsory 
education at age 15. An essential part of this follow-up is the measurement of the 
height and weight of the children, which are documented in the child welfare clinic 
records. These records also include information on the duration of breastfeeding, the 
body size and health of the child as a newborn, and socioeconomic factors during 
childhood. These records are filed in the archives of the healthcare center or in the 
archives of the municipality where the child was living when finishing school. As 
there was no information available on the possible relocation to a different 
municipality, the child welfare clinic records were only searched from the 
municipality and healthcare center of the place of birth. The records were inquired 
after from the 200 largest Finnish municipalities (with a population of over 3,500), 
either from the archives of the healthcare center or the municipality, depending on 
the practices of the municipality in question.   
 
Altogether 4,440 child welfare clinic records and 3,812 birth records were 
obtained. The birth weight measurements in birth records and child welfare clinic 
records were compared for persons for whom both were available. The recorded 
birth weight differed between the two sources by less than 100 g in 96.8% of the 
records and was identical in 93.4% of them.  
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4.3 Ethical aspects  
The study plan was approved by the National Advisory Board on Health Care 
Ethics. Birth records and child welfare clinic records were reviewed with the 
permission of the Ministry of Social Affairs and Health.   
 
4.4 Statistical methods 
All statistical analyses were performed using R-software (257).  A p-value of <0.05 
was considered to be statistically significant.  
 
Papers I-II 
The incidence of T1DM, T2DM, and undefined diabetes were analyzed separately. 
Sex- and age-specific incidence was calculated for 5-year age groups (15-19, 20-24, 
25-29, 30-34, and 35-39 years). Age-standardized annual incidence rates were 
calculated using WHO standard European population, where the age groups in 
question are identical in size. The observed cases were assumed to result from a 
Poisson distribution, and the exact 95% confidence intervals (CI) were 
approximated as described by Anderson et al. (258). The male-female (MF) ratio 
was calculated by age group for each diabetes type, and the corresponding 95% CI 
was evaluated as previously described (74). The effects of age, gender, and year of 
diagnosis were assessed using a generalized linear model for the Poisson family with 
a logarithmic link. 
 
Paper III 
Maternal age was analyzed both as a continuous and a categorical variable, and the 
mode for maternal age (25.5 years) was chosen as the baseline. Data on case-control 
pairs of T1DM and T2DM were analyzed separately. The effects of maternal age on 
the risk for both types of diabetes were analyzed using conditional logistic 
regression (259). A quadratic term was added to the model, as it displayed a better 
fit than a linear model, as measured by Akaike’s information criterion (AIC) (260). 
Categorical birth order was adjusted for maternal age. Birth orders 6 through 12 
were pooled into one category because of their low frequency in the data. The 
frequency of maternal age >44 years was also low, but this group was decided to be 
examined separately. It was tested that pooling maternal ages 40-44 and >44 
together would not have changed the results. The effect of birth order on the risk for 
diabetes was analyzed using conditional logistic regression. To test the interaction 
between birth order and maternal age, an interaction term was initially included in 
the model. This was, however, not found to be significant in either type of diabetes.  
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Paper IV 
The effects of birth weight and other perinatal exposures on the risk for diabetes 
were analyzed using conditional logistic regression. For birth weight, three different 
models were estimated: linear, quadratic and piecewise linear (261) with a single 
break point. The fits of the three models were compared using AIC. For the 
piecewise linear model, the location giving the best fit was chosen as the break 
point. Furthermore, a 95% basic bootstrapped confidence interval for the break point 
was estimated (262). Models including a quadratic term were also estimated for 
height, placental weight and gestational age, but a better model fit in terms of AIC 
was achieved with only linear terms. For each of the other variables (BMI and 
ponderal index at birth and maternal anthropometric measurements), only a linear 
model was estimated.  
 
Paper V 
Conditional logistic regression was used to evaluate the effect of the properties of 
individual BMI growth curves on the risk of developing T1DM or T2DM. In order 
to define the properties of the BMI growth curves, the ICP-model for human growth 
(188) was used as a starting point. This model breaks down growth into three 
additive components: infancy (0-3 years), childhood (3-11 years), and puberty (>11 
years), each component being a separate parametric function of age (the 
mathematical functions are described in (188)). Only the first two components were 
considered in the analyses due to the scarcity of measurements after 11 years of age. 
The parameters were first estimated using the least squares errors criteria. From each 
individual growth curve a set of characteristics were extracted to be used as 
explanatory variables in conditional logistic regression. The extracted characteristics 
were as follows: 
• the maximum BMI value in the infancy component  
• the age at which the maximum BMI value in the infancy component is reached  
• the minimum BMI value in the childhood component (the BMI rebound) 
• the age at which the minimum BMI value in the childhood component is reached. 
 
The results were adjusted for birth weight. For most individuals, the estimation 
of the infancy component was not possible due to too much variation in the BMI 
values between ages 0-2 years. Therefore, observed instead of estimated values were 
extracted from this component.  
 
The effect of breastfeeding on the risk for T1DM and T2DM was also examined 
using conditional logistic regression. 
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5 Results 
5.1 Diabetes incidence and trends in young adults (aged 15-39 
years) in Finland during 1992-2001 
 
Papers I-II 
After excluding cases of GDM and secondary forms of diabetes, the total number of 
young Finnish adults diagnosed with diabetes during 1992-2001 was 6,491. Of 
these, 47.4% (3,078/6,491) were classified as having T1DM, 36.9% (2,392/6,491) as 
having T2DM, and for 15.7% (1,021/6,491) the type of diabetes remained 
undefined. The incidence rates according to the type of diabetes, sex, and age at 
diagnosis are shown in Table 5. The incidence rates are presented per 100,000/year. 
 
The overall age-adjusted incidence of T1DM was 18.0 (95% CI 17.4-18.6), being 
22.4 (21.4-23.4) for men and 13.4 (12.6-14.2) for women. A significant male 
predominance in the incidence of T1DM was found across all examined age groups. 
The incidence was highest in the youngest 5-year age group (15-19 years) and 
decreased with increasing age. During the study period, the incidence of T1DM 
increased on average by 3.9% (2.7-5.3) per year (p<0.001) (Figure 6). 
 
The total age-adjusted incidence of T2DM was 12.9 (12.4-13.5). In both men and 
women, there was a considerable increase in the incidence after the age of 30. The 
highest incidence, 43.2 (40.3-46.2), was observed in men aged 35-39. In this age 
group, there was also a significant male predominance. During the study period, the 
incidence of T2DM increased on average by 4.3% (3.0-5.9) per year (p<0.001) 
(Figure 6).  
 
The incidence of undefined diabetes was 5.7 (5.3-6.0). The number of cases with 
undefined diabetes increased with age. The incidence of undefined diabetes 
remained stable during 1992-2001.   
 
 
 
 
 
 
 
 
 
  
Table 5.  Incidence of T1DM, T2DM and undefined types of diabetes in Finland during 1992-2001 
 
    Men Women Total M/F ratio 
  Age group 
(years) 
Cases (n) Incidence 
/100,000/y 
95% CI Cases (n) Incidence 
/100,000/y 
95% CI Cases (n) Incidence 
/100,000/y 
95% CI Ratio 95% CI 
15-19 509 30.4 27.8-33.2 272 17.0 15.0-19.1 781 23.9 22.2-25.6 1.8 1.41-2.27 
20-24 357 22.0 19.8-24.4 202 13.0 11.3-15.0 559 17.6 16.2-19.2 1.7 1.28-2.24 
25-29 409 24.0 21.7-26.5 221 13.6 11.8-15.5 630 18.9 17.5-20.4 1.8 1.36-2.31 
30-34 388 20.6 18.6-22.8 234 13.0 11.4-14.8 622 16.9 15.6-18.3 1.6 1.22-2.07 
35-39 288 14.7 13.1-16.5 198 10.5 9.1-12.1 486 12.6 11.5-13.8 1.4 1.04-1.88 
T1DM 
All age- 
adjusted  
1951 22.4 21.4-23.4 1127 13.4 12.6-14.2 3078 18.0 17.4-18.6 1.7   
15-19 8 0.5 0.2-0.9 16 1.0 0.6-1.6 24 0.7 0.5-1.1 0.5 0.11-1.93 
20-24 37 2.3 1.6-3.1 47 3.0 2.2-4.0 84 2.7 2.1-3.3 0.8 0.37-1.54 
25-29 98 5.8 4.7-7.0 154 9.4 8.0-11.1 252 7.6 6.7-8.6 0.6 0.40-0.92 
30-34 402 21.4 19.3-23.6 311 17.3 15.4-19.3 713 19.4 18.0-20.8 1.2 0.97-1.58 
35-39 846 43.2 40.3-46.2 473 25.1 22.9-27.5 1319 34.3 32.5-36.2 1.7 1.44-2.06 
T2DM 
All age- 
adjusted  
1391 14.6 13.9-15.4 1001 11.2 10.5-11.9 2392 12.9 12.4-13.5 1.3   
15-19 38 2.3 1.6-3.1 26 1.6 1.1-2.4 64 2.0 1.5-2.5 1.4 0.61-3.25 
20-24 37 2.3 1.6-3.1 52 3.4 2.5-4.4 89 2.8 2.3-3.5 0.7 0.34-1.36 
25-29 78 4.6 3.6-5.7 93 5.7 4.6-7.0 171 5.1 4.4-6.0 0.8 0.49-1.32 
30-34 155 8.2 7.0-9.7 132 7.3 6.1-8.7 287 7.8 6.9-8.7 1.1 0.77-1.65 
35-39 273 13.9 12.3-15.7 137 7.3 6.1-8.6 410 10.7 9.7-11.8 1.9 1.38-2.68 
Undef. 
Diabetes 
All age- 
adjusted  
581 6.3 5.8-6.8 440 5.1 4.6-5.6 1021 5.7 5.3-6.0 1.2   
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Figure 6. Observed and estimated incidence trends for T1DM and T2DM in 15-
39-year-old Finns.  
Observed incidence (dots), estimated trend (straight line), 95% confidence intervals 
(shaded area).  
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Figure 7. Distribution of diabetes types by age group (%) 
 
In the youngest age group of 15-19 years, 91% of all new cases of diabetes were 
of T1DM, whilst the proportion of cases with verifiable T2DM was only 3% (Figure 
7). After the age of 30 years, the proportion of cases with T1DM decreased to less 
than half of the new cases, and in the age group of 34-39 years, the share of T2DM 
was already 60%.  
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5.2 The effect of parental age and birth order on the risk for 
young adult-onset T1DM and T2DM 
 
Paper III 
All the case-control pairs for whom data on parents and siblings was available in the 
National Population Register (for the case and at least one of the controls) were 
included in the analyses. This resulted in the inclusion of 1,345 case-control pairs of 
T1DM and 1,072 case-control pairs of T2DM in the analysis of parental age, and 
1,272 pairs of T1DM and 943 pairs of T2DM in the analysis of birth order. (The 
original number of case-control pairs was 1,388 of T1DM and 1,121 of T2DM.)  
 
Maternal age was highly correlated with paternal age (correlation coefficient, 
=0.8) and therefore analysis was carried out using maternal age alone. The odds 
ratios (ORs), describing the effect size between the examined exposure and 
outcome, for T1DM and T2DM by maternal age and birth order adjusted for 
maternal age are presented in Table 6.  
 
Results of the conditional logistic regression showed that maternal age 
categorized into 5-year age groups or birth order adjusted for maternal age did not 
have any effect on the risk for young adult-onset T1DM (Table 6). The quadratic 
model for T1DM, where maternal age was treated as a continuous variable, also 
proved non-significant (Figure 8a).   
 
Instead, both maternal age and birth order adjusted for maternal age influenced 
the risk for young adult-onset T2DM in the offspring. Second [OR 0.76 (95%CI 
0.62-0.94)], third [OR 0.73 (0.55-0.95)], and fourth-born children [OR 0.66 (0.47-
0.94)] had a significantly lower risk for T2DM than the firstborn child (p<0.05) 
(Table 6). When maternal age was categorized into 5-year age groups, maternal age 
did not have a significant effect on the risk for T2DM in the offspring (Table 6). 
However, the categorical model suggested a U-shaped pattern for the effect. 
Therefore, a logistic regression model with a quadratic term was applied, where 
maternal age was treated as a continuous variable. The results of the quadratic model 
showed that compared to the mode maternal age of 25.5 years, the risk for T2DM 
was lowest in the offspring of mothers aged around 30 years, whereas the risk for 
T2DM increased towards younger and older maternal ages. (Figure 8b). The p-
values were 0.02 for both the linear and the quadratic terms.  
 
 
 
 
  
Table 6. Odds ratios (ORs) for T1DM and T2DM by maternal age and birth order adjusted for maternal age 
 
  T1DM T2DM 
Maternal age Cases (n) Controls (n) OR 95%  CI Cases (n) Controls (n) OR 95% CI 
15-19 95 201 0.88 (0.67-1.16) 75 125 1.28 (0.93-1.78) 
20-24 406 803 0.96 (0.81-1.41) 330 626 1.16 (0.95-1.42) 
25-29 431 824 1.00   273 602 1.00   
30-34 237 486 0.93 (0.77-1.13) 185 385 1.08 (0.86-1.36) 
35-39 112 229 0.92 (0.71-1.19) 114 206 1.24 (0.94-1.64) 
40-44 34 74 0.83 (0.54-1.28) 50 91 1.23 (0.84-1.80) 
>44 4 10 0.73 (0.23-2.34) 7 7 1.93 (0.64-5.81) 
Birth order                 
1st 559 1081 1.00   436 771 1.00   
2nd 400 795 0.94 (0.79-1.11) 227 501 0.76* (0.62-0.94) 
3rd 171 341 0.96 (0.76-1.22) 127 295 0.73* (0.55-0.95) 
4th 76 169 0.81 (0.59-1.12) 66 166 0.66* (0.47-0.94) 
5th 34 66 0.93 (0.58-1.48) 48 82 0.99 (0.65-1.50) 
6th+ 32 85 0.70 (0.44-1.11) 39 84 0.68 (0.43-1.06) 
*p<0.05 
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Figure 8. ORs for a) T1DM and b) T2DM according to maternal age.  
Estimated continuous model (black line) with 95% CI (dashed lines) and categorical 
models (circles). The quadratic term in b) was found to be significant. 
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5.3 The effects of perinatal exposures on the risk for young 
adult-onset diabetes 
 
Paper IV 
Recorded data on possible perinatal risk factors were available for 858 case-control 
pairs of T1DM and 355 case-control pairs of T2DM, and all these pairs were 
included in the analysis. Pregnancies with multiple fetuses were excluded. As data 
on newborns including weight and length were available in both birth records and 
child welfare clinic records, both of them were used. Birth records were used as the 
primary data source for birth weight and birth length. For individuals with an 
unavailable birth record, the child welfare clinic record was used as the data source. 
The demographic and anthropometric characteristics of the study subjects are 
presented in Table 7.  
 
 
Table 7. Mean values (SD) of the characteristics of the study subjects.  
Grey areas indicate significant differences (according to t-test) in mean values 
between cases and controls.  
 
    Men Women 
    Cases Controls Cases Controls 
Age at diagnosis 26.4 (6.98)   26.0 (7.31)   
Birth weight, kg 3.6 (0.56) 3.6 (0.50) 3.5 (0.48) 3.5 (0.5) 
Birth length, cm 50.8 (2.32) 50.8 (2.11) 49.9 (1.97) 50.1 (1.99) 
Gestational age, d 278.7 (13.44) 279.3 (13.76) 278.8 (12.76) 278.8 (13.00) 
Placental weight, kg 0.6 (0.13) 0.6 (0.13) 0.6 (0.12) 0.6 (0.12) 
Maternal height, cm 163.1 (5.27) 162.3 (5.62) 162.3 (5.25) 162.7 (5.63) 
T1DM 
Maternal weight, kg 59.2 (8.71) 58.0 (8.94) 58.9 (8.41) 59.1 (9.04) 
Age at diagnosis 35.0 (3.96)   33.2 (4.73)   
Birth weight, kg 3.4 (0.60) 3.6 (0.55) 3.3 (0.62) 3.4 (0.49) 
Birth length, cm 50.2 (2.49) 50.7 (2.41) 49.6 (2.19) 50.1 (1.99) 
Gestational age, d 277.1 (15.71) 276.8 (15.01) 280.2 (15.12) 275.4 (20.39) 
Placental weight, kg 0.6 (0.12) 0.6 (0.13) 0.6 (0.12) 0.6 (0.13) 
Maternal height, cm 160.7 (5.42) 161.1 (5.88) 160.7 (6.61) 161.4 (5.34) 
T2DM 
Maternal weight, kg 59.6 (9.53) 60.3 (6.84) 58.9 (10.70) 59.2 (8.45) 
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Results of the conditional logistic regression showed that none of the examined 
perinatal factors (body size at birth, placental weight, gestational age, and maternal 
body size) influenced the risk for young adult-onset T1DM. Adjusting placental 
weight for birth weight did not affect the results. Results of the continuous linear 
model for T1DM are reported in Table 8.  
 
Table 8. Odds ratios (ORs) for T1DM in young Finnish adults by the examined 
perinatal exposures (linear model) 
 
Examined variable Adjusted 
for 
OR (95% CI) p-value n 
Birth weight (per 1 kg)   0.92 (0.77-1.10) 0.31 2663 
Birth length (per 1 cm)   0.99 (0.95-1.03) 0.57 2533 
BMI at birth (per 1 kg/m2  )   0.96 (0.89-1.03) 0.21 2529 
PI at birth (per 1 kg/m3 )   0.98 (0.94-1.02) 0.28 2529 
Placental weight (per 100 g)   0.94 (0.84-1.05) 0.29 1410 
Placental weight (per 100 g) Birth weight 1.00 (0.86-1.15) 0.95 1405 
Gestational age (per d)   1.00 (0.99-1.00) 0.38 1667 
Maternal weight prior to pregnancy 
(per 1 kg) Birth weight 1.02 (0.996-1.03) 0.12 954 
Maternal height (per 1 cm) Birth weight 1.02 (0.997-1.05) 0.08 1401 
Maternal BMI (per 1 kg/m2) Birth weight 1.03 (0.97-1.10) 0.28 860 
Maternal weight prior to childbirth 
(per 1 kg) Birth weight 1.01 (0.99-1.02) 0.46 1440 
 
 
The association between birth weight and the risk for T2DM was estimated using 
three alternative models. According to the conditional logistic regression model with 
a linear regression term, the OR for T2DM was 0.61 (95% CI 0.47-0.79) per 1 kg 
increase in birth weight (p<0.001) (Table 9). The quadratic model for birth weight 
was not significant. The piecewise linear model (Figure 9) showed that the risk for 
T2DM decreased until the birth weight of 4.2 kg (95% CI 3.05-5.55 kg) and then 
began to increase. The OR for T2DM was 0.49 (95% CI 0.37-0.66) per 1 kg increase 
in birth weight until 4.2 kg (p<0.001), and from 4.2 kg onwards the OR for T2DM 
was 4.8 (95% CI 1.32-17.62) per 1 kg increase in birth weight (p=0.018). With birth 
weights higher than 4.2 kg, the interaction between sex and birth weight was 
statistically significant. When men and women were examined separately, the 
increased risk for T2DM after 4.2 kg was not significant in men. In women the 
increase in the risk for T2DM remained significant, but because the number of cases 
was small the OR was unreliable. The piecewise linear model displayed the best fit 
as measured by AIC. The AIC’s for the linear, quadratic and piecewise linear 
models were 638.8, 635.0 and 630.9 respectively. Gestational age did not have an 
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effect on the subsequent risk for T2DM and therefore birth weight was not adjusted 
for gestational age. 
 
 
 
Table 9. Odds ratios (ORs) for T2DM in young Finnish adults by the examined 
perinatal exposures. 
 
Model Examined variable Adjusted 
for 
OR (95% CI) p-value n 
Birth weight <4.2 kg (per 1 kg)   0.49 (0.37-0.66)* <0.01 1045 
Birth weight 4.2 kg (per 1 kg)   4.8 (1.32-17.62)* 0.018 91 
 Birth weight <4.2 kg (per 1 kg)   0.50 (0.34-0.72)* <0.01 593 
 Birth weight 4.2 kg (per 1 kg)   1.74 (0.38-8.07) 0.48 69 
 Birth weight <4.2 kg (per 1 kg)   0.42 (0.26-0.69)* <0.01 452 
Piecewise 
linear  
 Birth weight 4.2 kg (per 1 kg)   >20 (95% CI lower 
limit)* 
<0.01 22 
Birth weight (per 1 kg)   0.61 (0.47-0.79)* <0.01 1136 
Birth length (per 1 cm)   0.88 (0.81-0.95)* <0.01 963 
BMI at birth (per 1 kg/m2)   0.81 (0.73-0.90)* <0.01 962 
PI at birth (per 1 kg/m3)   0.91 (0.86-0.97)* <0.01 962 
Placental weight (per 100 g)   0.77 (0.61-0.98)* 0.03 341 
Placental weight (per 100 g) Birth weight 0.80 (0.61-1.06) 0.12 340 
Gestational age (per d)   1.00 (0.99-1.02) 0.72 529 
Maternal weight prior to 
pregnancy (per 1 kg) 
Birth weight 1.02 (0.95-1.10) 0.53 129 
Maternal height (per 1 cm) Birth weight 0.98 (0.94-1.03) 0.45 348 
Maternal BMI (per 1 kg/m2) Birth weight 1.32 (1.00-1.74)* 0.047 110 
Linear 
Maternal weight prior to 
childbirth (per 1 kg) 
Birth weight 1.03 (0.99-1.07) 0.17 366 
*p<0.05  men women 
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Figure 9. Odds ratio (OR) for young adult-onset T2DM by birth weight (black 
line) with 95% CIs (red lines). The piecewise linear model. 
 
In addition to the analysis of the effect of birth weight on the risk for T2DM, the 
effects of birth length, BMI, and ponderal index (PI) at birth were also examined. 
The ORs for T2DM were 0.88 (95% CI 0.81-0.95) for every 1 cm increase in birth 
length (p<0.001), 0.81 (95% CI 0.73-0.90) per 1 kg/m2 increase in BMI at birth 
(p<0.001), and 0.91 (95% CI 0.86-0.97) per 1 kg/m3 increase in PI at birth 
(p=0.0031).  
 
The risk for T2DM was lower in children with large placentae, the OR for T2DM 
was 0.77 (95% CI 0.61-0.98) per 100 g increase in placental weight (p=0.03). 
However, when adjusted for birth weight, the effect of placental weight was no 
longer significant. The effects of maternal body size (height, weight, BMI prior to 
pregnancy, and weight prior to childbirth) were examined, and no associations with 
the risk for T2DM in the offspring were found. When adjusted for birth weight, the 
OR for T2DM was 1.32 (95% CI 1.00-1.74) per 1 kg/m2 increase in maternal BMI 
before pregnancy (p=0.047). 
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5.4 The effect of childhood BMI trajectories on the risk for 
young adult-onset diabetes 
Paper V 
From the 4,440 child welfare clinic records obtained, it was possible to form 607 
case-control pairs with T1DM and 324 case-control pairs with T2DM for whom 
child welfare clinic records were available for the diabetes patient and for at least 
one of the controls. Twenty individuals were excluded as they had no valid 
anthropometric observations. Only the case-control pairs with sufficient growth data 
to estimate the BMI growth curve (at least three height and weight measurements 
within a time axis that permitted the fitting of the quadratic function) were included 
in the analyses, and therefore the final number of case-control pairs was 218 (160 
with one control and 58 with two controls) for T1DM and 64 (52 with one control 
and 12 with two controls) for T2DM. The average number of measurements (height 
and weight) per child was 7.3 (0-32) between ages 0-3 years, 5.7 (0-22) between 3-
11 years, and 3.8 (0-19) for those over 11 years of age. Visually, the BMI growth 
trajectories of the patients with young adult-onset T1DM were close to those of their 
controls (Figure 10). 
 
 
 
Figure 10. BMI growth curves of cases of T1DM and their controls.  
Cases (dashed line), controls (solid line), individual observations (grey circles). BMI 
values are kg/m2. 
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The analysis of BMI characteristics among case-control pairs with T1DM 
showed that the risk for T1DM increased 1.19-fold with every 1 kg/m2 increase in 
the infancy maximum BMI between ages 0-2 years (p=0.02). There were no age 
differences in the timing of the infancy maximum BMI. In addition, the level of 
BMI at the BMI rebound between ages 3-11 was similar in individuals with T1DM 
and control subjects. The age of the BMI rebound between ages 3-11 was slightly 
but not significantly lower in individuals with T1DM. Adjusting the BMI analysis 
for birth weight did not significantly affect the results. The odds ratios describing the 
effect sizes for the examined childhood BMI characteristics on the risk for young 
adult-onset T1DM are presented in Table 10. (The maximum BMI in infancy and 
the BMI rebound are illustrated in Figure 2.) 
 
Table 10. The odds ratios (ORs) for young adult-onset T1DM according to 
childhood BMI characteristics (218 cases and 276 controls) 
 
Examined characteristic OR (95% CI) p-value OR (95% CI)* p-value* 
Maximum BMI during the first 2 
years of age (per 1 kg/m2) 
1.19 (1.03-1.36) 0.02 1.21 (1.05-1.41) 0.01 
Age at maximum BMI (per year)  1.16 (0.82-1.65) 0.41 1.14 (0.80-1.64) 0.48 
Minimum BMI at 3 to 11 years of age   
(per 1 kg/m2) 
0.90 (0.73-1.10) 0.29 0.88 (0.70-1.09) 0.23 
Age at minimum BMI (per year) 0.87 (0.75-1.02) 0.09 0.88 (0.75-1.03) 0.11 
*Adjusted for birth weight 
 
The data analysis of the case-control pairs with T2DM showed that the infancy 
maximum BMI and the age at the infancy maximum BMI between ages 0-2 years 
were similar between the cases and the controls. The risk for T2DM was strongly 
affected by the level of BMI at the BMI rebound. A gain of 1 kg/m2 in the minimum 
BMI increased the risk for T2DM 1.77-fold (p=0.04). The effect became stronger 
when adjusted for birth weight: the risk for T2DM increased 1.87-fold per every 1 
kg/m2 gain in the minimum BMI (p=0.04). In individuals with T2DM, the BMI 
rebound seemed to occur at a younger age, but the effect was not statistically 
significant. An excess BMI gain in individuals who develop young adult-onset 
T2DM already began in early childhood after the age of the BMI rebound. The risk 
for T2DM increased 12-fold (95% CI 1.68-88.3, p=0.013) for every 1 (kg/m2)/year 
increase in the rate of BMI gain between the age of the BMI rebound and 11 years. 
The odds ratios for young adult-onset T2DM according to childhood BMI 
characteristics are presented in Table 11. Visually, the growth patterns of the 
patients with young adult-onset T2DM were prominently aberrant (Figure 11). 
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Table 11. The odds ratios (ORs) for young adult-onset T2DM according to 
childhood BMI characteristics (64 cases and 76 controls)   
 
Examined characteristic OR (95% CI) p-
value 
OR (95% CI)* p-
value* 
Maximum BMI during the first 2 
years of age (per 1 kg/m2) 
0.91 (0.59-1.41) 0.69 0.93 (0.59-1.48) 0.77 
Age at maximum BMI (per year) 0.69 (0.28-1.70) 0.42 0.79 (0.29-2.07) 0.63 
Minimum BMI at 3 to 11 years of 
age (per 1 kg/m2) 
1.77 (1.04-3.00) 0.04 1.87 (1.04-3.37) 0.04 
Age at minimum BMI (per year) 0.75 (0.53-1.06) 0.11 0.75 (0.52-1.09) 0.13 
*Adjusted for birth weight 
 
 
 
 
 
Figure 11. BMI growth curves of cases of T2DM and their controls.  
Cases (dashed line), controls (solid line), individual observations (grey circles). BMI 
values are kg/m2. 
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Information about the duration of breastfeeding was available in 21.5% of the 
records (of the original 607 case-control pairs of T1DM and 324 case-control pairs 
of T2DM). It was on average 2.9 months (0-43 months). Both the duration of 
breastfeeding and the status of breastfeeding versus bottle feeding were compared, 
and there were no differences between the cases of T1DM and T2DM and their 
respective controls in the status or duration of breastfeeding (Table 12). 
 
Table 12. The odds ratios (ORs) for young adult-onset T1DM and T2DM 
according to feeding practice in infancy   
 
  Examined variable OR (95% CI) p-
value 
Number of 
observations 
Months of breastfeeding 
(per 1 mo) 
0.97 (0.92-1.02) 0.25 916 T1DM 
Status of breastfeeding 
(yes vs. no) 
0.96 (0.53-1.73) 0.88 916 
Months of breastfeeding 
(per 1 mo) 
0.93 (0.83-1.05) 0.26 374 T2DM 
Status of breastfeeding 
(yes vs. no) 
0.81 (0.33-2.00) 0.64 374 
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6 Discussion 
6.1 Diabetes incidence and trends among young Finnish 
adults 
 
Type 1 diabetes 
The results of this population-based study showed that the high risk for T1DM 
among Finnish individuals extends to at least 39 years of age. The average incidence 
of T1DM among 15-39-year-old Finns during 1992-2001, 18.0 per 100,000/year, 
was higher than previously reported of other European populations (96, 101, 102, 
104) (Table 2). The average incidence in Sardinia has been reported to be slightly 
higher, 18.8 per 100,000/year (94), but the Sardinian data only included individuals 
up to the age of 29. Comparing incidence rates internationally is difficult, as the 
incidence rates from most other countries are from an earlier period. However, a 
small study in Kronoberg county (Sweden) (108) comprised a comparable period 
from 1998 to 2001, and the incidence of T1DM among young adults observed there 
was close to the incidence observed in this study among young Finnish adults (Table 
2). 
 
Although the incidence of T1DM among young Finnish adults during 1992-2001 
was high on a global scale, it was considerably lower than among Finnish children 
during the same period (91). The age distribution of new cases of T1DM in Finland 
(Figure 12) was similar to the age distribution in other European populations with a 
high incidence of T1DM (102). It has been shown that in the areas with a high 
incidence of childhood-onset T1DM, the incidence falls steeply after 15 years of 
age, whereas in the populations with a lower incidence of childhood-onset T1DM, 
the incidence decreases gradually with age or remains on the same level as observed 
in childhood (102). This phenomenon may indicate a more aggressive disease 
progression among individuals living in high incidence areas, causing a larger 
proportion of all T1DM cases to appear already before the age of 15.  
   
The observed 1.7-fold male predominance in the incidence of T1DM among 
young Finnish adults is consistent with the results from other countries (93, 96, 105, 
109). The cause for the male predominance is unknown. Differences in 
susceptibility to viral infections (96), and a metabolic burden caused by android fat 
distribution (102) have been suggested as possible explanations.   
 
Globally, the incidence of T1DM among children under the age of 15 has been 
increasing for decades (83), and thus it can be assumed that the same phenomenon 
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also prevails among older individuals. According to this study, the incidence of 
T1DM among young Finnish adults increased on average 3.9% per year during 
1992-2001, which is comparable to the 4.2% average annual increase observed in 
Finnish children during the same period (6). Thus, there is no evidence that the 
incidence of T1DM in Finnish children would be increasing merely due to the 
younger age of diabetes onset, as suggested with regard to Swedish children (263). 
However, a longer observation period is needed in order to draw definitive 
conclusions on whether the incidence of T1DM is permanently increasing among 
young Finnish adults, as the incidence trends may show fluctuation over time. For 
example, a comparison to an earlier Finnish study (82) suggests that the incidence of 
T1DM among 15-19-year-old Finns has not changed in the course of 20 years (24.1 
per 100,000/year between 1970-1979 vs. 23.9 per 100,000/year between 1992-
2001).   
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Figure 12. The incidence of T1DM in Finnish children and young adults. 
Incidence for age groups 0-4, 5-9, and 10-14 years are adopted from Rytkönen 
(91). Males (diamonds) and females (squares). 
Note: Data for 0-14-year-old individuals is for the years 1987-2001 and collected 
with a different method (91). 
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Type 2 diabetes 
The results concerning the incidence of T2DM confirmed that the epidemic of 
youth-onset T2DM has reached Finland. The total age-adjusted incidence of young 
adult-onset T2DM was 12.9 per 100,000/year, indicating that a considerable number 
of Finns are diagnosed with T2DM before the age of 40. Although the incidence of 
T2DM was still low in the youngest examined age groups, it started to increase 
rapidly after the age of 30, especially in men. Due to the register-based approach of 
this study, all the cases with T2DM treated only with lifestyle counseling could not 
be captured, and this study provided no information on the undiagnosed cases of 
T2DM. Therefore, the incidence estimates for T2DM reported within this study are 
conservative.   
 
Although the highest numbers of youth-onset T2DM have been reported in non-
Europid ethnic groups, the age of diagnosis of T2DM has also decreased in 
populations of Europid origin (123). The incidence rates of T2DM are difficult to 
compare between countries, as most previous studies on the occurrence of T2DM 
are based on prevalence rates or are case studies. However, the incidence of young 
adult-onset T2DM in Finland is low compared to the recent incidence data from the 
USA (128). The incidence of T2DM was 5.6 per 100,000/year among the 15-19-
year-old population of Europid origin in the USA, whereas according to this study, 
the incidence of T2DM among the same age group in Finland was only 0.7 per 
100,000/year.  
 
The incidence of T2DM among young adults increased rapidly during the ten-
year study period: the average annual increase in incidence was 4.3%. Since the 
standardized forms, filled in at hospitals and primary care clinics, were not available 
for the second half of the study (1997-2001), this may have caused cases of T2DM 
to fall out from the end of the study period. Therefore, the estimated annual increase 
of 4.3% per year was, albeit high, probably underestimated. This increase in young 
adult-onset T2DM among Finns is in accordance with reports of an emerging 
worldwide epidemic of youth-onset T2DM (2, 122, 132), and further supported by 
observed increases in obesity (135) and metabolic syndrome (138) among the 
Finnish youth. As T2DM takes years to develop, health problems in these 
individuals may begin as early as in their teens. When an increasing number of 
young adults are already diagnosed with T2DM at the beginning of working age, 
this disease inflicts an unfavorable effect on the health of the working population. 
On average 200 Finns of less than 40 years of age are diagnosed with T2DM 
annually, and this number increases by ten individuals each year. If this increasing 
trend cannot be reversed, young adult-onset T2DM among Finns will become a 
major public health problem in the near future. 
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Undefined diabetes 
The type of diabetes remained undefined in approximately 16% of the cases 
included in this study. This amount is comparable to the estimated amount of LADA 
(25% of individuals with a diagnosis of T2DM before the age of 34) (264). 
However, all of the 1,021 individuals classified as having undefined diabetes in this 
study are probably not cases of LADA; among them are also cases of T2DM with 
inadequate information for classification. This assumption is supported by the higher 
incidence of undefined diabetes in older age groups. As blood was not drawn from 
the study subjects, a more precise classification based on autoantibody and C-
peptide measurements was not possible in this study.  
 
The incidence of undefined diabetes remained stable during 1992-2001, 
indicating that the observed increases in the incidence of T1DM and T2DM during 
the same period were not caused by classification bias.    
 
6.2 Perinatal and early childhood exposures 
 
The analysis of the effects of perinatal exposures was divided in two parts: maternal 
age and birth order (paper III) and other perinatal exposures (paper IV). The 
objective of this was to include as many case-control pairs as possible in each 
analysis. As data on maternal age and birth order could be obtained from the 
National Population Register, almost all of the diabetes cases diagnosed during 
1992-1996 and their controls could be included in the analyses presented in paper 
III. The availability of data on other perinatal exposures analyzed in paper IV was, 
however, dependent on the availability of birth records and child welfare clinic 
records, and therefore these analyses formed another logical entity. In paper V, the 
focus was on postnatal growth.  
6.2.1 Perinatal and early childhood exposures and the risk for young 
adult-onset T1DM 
 
According to the results of this study, perinatal exposures such as maternal age, 
parity, or body size at birth did not have any effect on the incidence of young adult-
onset T1DM. This observation is in agreement with earlier studies that have 
emphasized the age of diabetes onset: the risk-modifying effects of maternal age 
(166), birth order (169), and birth weight (204) have all been reported to be 
restricted to very young-onset cases of T1DM. Gestational age, placental size or 
maternal body size did not have any effect on the incidence of young adult-onset 
T1DM in this study either. It appears that in young adult-onset T1DM, the 
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environmental factors triggering -cell destruction do not operate in the perinatal 
period, but rather later in life. 
 
Instead, previous findings indicating that a high BMI in infancy increases the risk 
for childhood-onset T1DM (12, 209) are confirmed, and the results of this study 
show that this also applies to young adult-onset cases. Fast BMI growth in infancy 
among these individuals may be caused by a common genetic trait between growth 
and T1DM, or by nutritional factors. However, as a nutritional factor in infancy, the 
duration of breastfeeding did not explain the risk in our dataset. As there is a long 
time period between breastfeeding and young adult-onset T1DM, the possible effect 
of breastfeeding on the development of T1DM may be weaker than in childhood-
onset cases, and therefore undetectable. Unlike in childhood-onset T1DM (12), 
differences in BMI between cases of young adult-onset T1DM and their control 
individuals leveled out by the age of the BMI rebound. Therefore, it is unlikely that 
the increasing incidence of young adult-onset T1DM in Finland would be caused by 
increasing overweight in Finnish adolescents. 
6.2.2 Perinatal and early childhood exposures and the risk for young 
adult-onset T2DM 
 
The analysis including 1,072 case-control pairs of T2DM revealed a U-shaped 
association between maternal age and the risk for T2DM in the offspring. In 
addition, second to fourth born children were observed to have a lower risk for 
T2DM compared to the firstborn. The observed differences in the risk for T2DM 
attributed to maternal age or birth order were small. 
 
The most feasible explanation for these observations is the effect of maternal age 
and parity on birth weight: firstborn children are generally smaller than the 
subsequent ones (185). In addition, intrauterine growth retardation and prematurity, 
both resulting in low birth weight, are more frequent at the extremes of maternal age 
(265). The possible confounding effect of birth weight would have been interesting 
to explore further, but this was not possible within this study due to the lack of data 
on birth weight for part of the study subjects.  
 
The results of this study confirmed earlier observations of an increased risk for 
T2DM in individuals born with low birth weight (221, 227). In addition to low birth 
weight, shortness, a low BMI, and a low PI at birth were found to be risk factors for 
young adult-onset T2DM. The association between low birth size and T2DM may 
be caused by in utero programming of a thrifty metabolism (220). However, other 
possible explanations, such as epigenetic modification (250) and gene-environment 
interactions (251), also need to be considered.  
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Because it has been argued that the relationship between birth weight and T2DM 
may not be linear (231, 232), other models were also fitted to the birth weight data 
in this study. The best fit was achieved with the piecewise linear model, which 
indicated that the risk for T2DM may also be elevated in very high birth weight 
babies. However, a larger number of study subjects are needed in order to define the 
“threshold” birth weight after which the risk for type 2 diabetes starts to increase. 
The increased risk for T2DM among individuals born with high birth weight may be 
caused either by the metabolic effects of maternal hyperglycemia, a genetic 
susceptibility to T2DM inherited from the mother, or both.  
 
Birth weight is affected by the fetal nutritional supply via the placenta. Indirect 
information on the placental transfer capacity can be obtained by measuring the 
placental size (266). In this study, low placental weight increased the risk for T2DM, 
but this effect was no longer significant after adjusting for birth weight. Therefore, it 
seems that the variation in birth weight explains the increased risk in persons born 
with small placentae. On the other hand, it is also possible that there are some other 
factors, such as genetic growth potential or maternal nutrition during pregnancy, 
affecting both birth weight and placental weight. According to this study, a high 
pregestational BMI in the mother increased the offspring’s risk for T2DM 
independently of birth weight. The reason for this may be a genetic predisposition to 
obesity and T2DM in both the mother and the child.     
 
In accordance with earlier observations (11, 236), the average age of the BMI 
rebound was slightly (non-significantly) lower in individuals with T2DM than in 
their control subjects. It has been suggested that the early BMI rebound may result 
from lower lean mass in the individuals with T2DM (11). The results of this study 
also demonstrated an increased risk for T2DM to be related to the level of BMI at 
the time of the BMI rebound, indicating that the total weight gain from birth to the 
BMI rebound was greater in individuals with T2DM. In agreement, a British-
Chilean study showed that compared to infants born appropriate for gestational age, 
infants born small for gestational age did not have insulin resistance at birth, but 
developed it during their first 3 years of life. This transition was associated with 
rapid postnatal weight gain (267).  
 
In this study, the rapid increase in BMI in individuals with T2DM already began 
at a very young age after the age of the BMI rebound. The rapid increase of BMI in 
adolescence associates strongly with central obesity in adults (268), which in turn 
markedly increases the risk for T2DM. In this study, low birth weight predicted a 
high BMI at the time of the BMI rebound, which preceded rapid BMI growth 
thereafter. Therefore, it appears that low birth weight may cause T2DM in young 
Finnish adults at least in part through programming an increased tendency for adult 
  
THL – Research 22/2009 73 Type 1 and type 2 diabetes 
among young adults in Finland 
 
central obesity. A high BMI at the BMI rebound may only be an intermediate phase 
in this progression.  
 
Previous findings concerning the protective effect of breastfeeding against 
T2DM (240, 269) could not be confirmed in this study. The possible effect of 
breastfeeding may be too weak to be detected by retrospective data collection, as 
information on breastfeeding was only recorded in a minority of the child welfare 
clinic records. Although the used case-control setting is efficient in reducing 
variations in the quality of data (such as different practices between child welfare 
centers), it is possible that the duration of breastfeeding was recorded more often if a 
child was growing aberrantly, causing bias in the data selection.    
 
The perinatal risk factors for young adult-onset T2DM observed in this study - 
maternal age extremes, low and very high birth weight, and rapid BMI gain in 
childhood - have potential effects on public health. The long-term health effects of 
low birth weight are affecting elderly people today. However, instead of low birth 
weight, the adverse effects of high birth weight, high maternal age, and rapid BMI 
gain in childhood may be emphasized among Finns in the future. An increasing 
prevalence of GDM (270), a rising proportion of parturients aged >35 years (271), 
and increasing childhood obesity (135, 136) may elevate the risk for T2DM among 
new generations of young Finnish adults. However, whilst preventing low birth 
weight is difficult, interventions against GDM and childhood obesity are feasible 
and should be acted upon.  
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6.3 Methodological considerations 
 
The methodological aspects of the chosen study design, an incidence study 
conducted in a Finnish cohort followed by an incident case-control study, need to be 
discussed. When conducting an incidence study in Finland, where precise 
demographic data is readily available, the main methodological concern is the 
completeness of case-ascertainment. In addition, when evaluating the validity of the 
following case-control study, the quality of the exposure data, the methods of case-
control selection, and statistical power need to be assessed. Finally, although the 
exposure data (such as birth weight) in this study were recorded prospectively, the 
tracing of the records was retrospective, which needs to be taken into consideration.  
 
The accuracy and coverage of the Finnish national healthcare registers have been 
confirmed to be excellent (5, 272). For example, the overall sensitivity of the 
Hospital Discharge Register (HDR) in detecting diagnoses of myocardial infarction 
has been reported to be 83%, and the positive predictive value was 90% (5). In 
addition, the Drug Reimbursement Register (DRR) is a reliable data source, because 
the reimbursement of medication costs provides the patient with a marked financial 
benefit and consequently most patients with drug-treated diabetes apply for this.  
 
Despite the good quality of the Finnish register data, there are several aspects 
that need to be considered regarding the trends in incidence observed in this study. 
While it can be assumed that >90% of cases with young adult-onset T1DM could be 
captured with the applied method (insulin purchases are found in the Drug 
Prescription Register (DPR) and entitlement to free-of-charge medication is found in 
the DRR), some of the new cases of young adult-onset T2DM were probably 
missed. As discussed above, undiagnosed cases of T2DM could not be captured with 
this register-based method. Therefore, the results of this study should be interpreted 
as concerning only diagnosed cases of T2DM, whilst the proportion of undiagnosed 
cases is estimated to be substantial (44). Data obtained from the DPR did not cover 
the first two years of the study period, which may have caused some cases of 
T2DM, which were not reported by diabetes nurses or listed in the HDR, to fall out 
from the first study years thereby heightening the upward trend in the incidence of 
T2DM. On the other hand, the standardized forms filled in by diabetes nurses were 
not collected in the second half of the study, leading to the opposite effect on the 
observed trend. In addition, the threshold FPG for the diagnosis of diabetes was 
lowered in 1997, which probably increased diagnoses thereafter. Due to the above 
mentioned reasons, although all the evidence obtained from this study and other 
Finnish studies (which examine other health indicators such as obesity among the 
Finnish youth) refers to an increasing trend in young adult-onset T2DM, the exact 
rate of the increase needs to be confirmed with a longer study period. The 
  
THL – Research 22/2009 75 Type 1 and type 2 diabetes 
among young adults in Finland 
 
prevention programme for T2DM in Finland, the D2D project of the Development 
Programme for the Prevention and Care of Diabetes in Finland (DEHKO) (7), was 
not launched until 2003, and therefore did not influence the incidence of T2DM 
during this study period.  
 
Regarding the analysis of the effects of maternal age and birth order, Finland is 
the optimal place to conduct this kind of study: the unique personal identification 
number, assigned to every Finnish resident in the early 1970s and since then 
assigned at birth or after immigration, allows the unequivocal identification of the 
study subjects and their relatives from the National Population Register. However, it 
was only possible to detect nuclear families, and half-siblings were not included in 
the analyses. As a result, the sizes of the examined families were smaller than in 
reality, and the number of first-borns was exaggerated. It is unlikely that this had 
any effect on the results, as the same was true for the control families.  
 
The anthropometric data used for examining the effects of perinatal exposures 
and childhood growth was not subjected to recall bias because it was obtained from 
official records filled in by healthcare professionals and validated by comparing 
records of the same person. However, this data was missing for part of the study 
subjects. Due to the fact that the child welfare and birth records were filed in a large 
number of different archives, only 40% of the birth records and 47% of the child 
welfare clinic records searched for were found. The shortage of data for the case-
control pairs with T2DM was more substantial. The reason for this was the older 
average age of individuals with T2DM (and their birth date matched control 
individuals), which is why their child welfare clinic records and birth records were 
more difficult to trace. Fortunately, there is no reason to expect that the examined 
perinatal factors would vary depending on whether the record was later found or not. 
Because the child welfare clinic records were only collected from the 200 largest 
municipalities, the case-control pairs were matched by place of birth in order to 
avoid possible bias caused by the lack of data from sparsely populated areas. 
 
Only the case-control pairs with sufficient records of growth data could be 
included in the BMI growth analysis. Due to the retrospective approach of this 
study, it is possible that individuals with aberrant growth patterns were measured 
more frequently than individuals who were growing on the standard curve, and 
therefore they were included in the study more often. The case-control setting of this 
study is efficient in reducing the possible errors caused by the uneven frequency of 
measurements, as it was confirmed that the reason for the exclusion of a case-control 
pair was equally often the shortage of data for the case as for the control. This 
indicates that there was a corresponding proportion of extra-frequently measured 
(i.e. possibly aberrantly growing) case and control individuals in the examined 
dataset. 
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Like in all studies, it is important to consider whether the statistical power of this 
study was adequate enough to detect the explored phenomenon. In this study, birth 
weight was not found to have any effect on the risk for young adult-onset T1DM. In 
order to examine the statistical power of this analysis, the statistical power of the 
study was evaluated as a function of the effect size (Figure 13). The results of this 
simulation showed, for example, that a 40% increase (or decrease) in the risk for 
T1DM per 1 kg change in birth weight would have been detectable by a probability 
of 80% with the chosen significance level of 5%. It can therefore be concluded that 
the study’s statistical power was adequate enough to show clinically relevant effects 
on the risk for T1DM attributed to birth weight.  
 
 
 
 
Figure 13. Statistical power of the study as a function of the effect size for three 
different significance levels, .  
The curves are numerically evaluated for the linear model of the effect of 1 kg 
additional birth weight on the log-odds-ratio for T1DM. The simulations are done 
for 1,000 case-control pairs (assuming that the birth weights in the populations are 
normally distributed with mean and SD estimated from the total sample). 
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Within this study, it was not possible to control for all the confounding factors 
that may influence the association between the examined perinatal exposure and 
young adult-onset diabetes. Information on socio-economic factors during childhood 
was available for the study, as the father’s occupation was recorded in the majority 
of the healthcare records. However, the study subjects were born within a long time 
period (1952-1981), during which the socio-economic structure of the Finnish 
population changed essentially, making adjustment for social class impossible. 
During the study period, virtually all of the pregnant mothers attended regular 
examinations in ante-natal clinics and took their newborns to child welfare clinics, 
thus decreasing the differences in health care use between social classes. 
 
The potential effects of parental diabetes could not be examined in this study. In 
the birth records, only 39 out of 3,812 mothers were recorded as having diabetes or 
glucosuria during pregnancy, which was not considered sufficiently reliable 
information to be included in the analyses. As there is a significant predisposition to 
both types of diabetes, it can be assumed that there were more diabetic parents in the 
families of the diabetes cases than in the control families, and maternal diabetes may 
have caused the increased risk for T2DM observed in individuals born with very 
high birth weight.  
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7 Conclusions 
This is the first study to provide population-based information on the incidence of 
both T1DM and T2DM among young Finnish adults. In addition, the possible risk 
factors for young adult-onset T1DM and T2DM related to the conditions during 
early life are extensively explored within this study.   
 
The conclusions related to the specific aims are:  
 
• The risk for T1DM among the Finnish population remains high throughout 
young adult age. During the years 1992-2001, the incidence of T1DM among 
young Finnish adults increased annually by 3.9%.  
 
• Approximately 200-300 young Finnish adults under the age of 40 are annually 
diagnosed with T2DM. Moreover, concomitantly with increasing obesity and 
decreasing physical activity among the Finnish youth, the incidence of young 
adult-onset T2DM increased by 4.3% per year in Finland during 1992-2001.  
 
• Rapid growth during the first years of life may be a risk factor for young adult-
onset T1DM.  
 
• Conditions during fetal development and childhood are associated with the risk 
for young adult-onset T2DM. Better knowledge of the developmental 
programming of T2DM will aid better risk profiling and individualized lifestyle 
counseling.   
 
• The primary prevention of T2DM should also focus on the prevention of 
childhood and adolescent obesity, as the excess weight gain in individuals with 
T2DM already begins during early childhood.  
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8 Future directions  
• In order to assess the public health implications of young adult-onset diabetes, 
monitoring the incidence of T1DM and T2DM among young Finnish adults 
should be continued, and the prevalence of T2DM among young Finnish adults 
should be investigated. 
 
• Results obtained from studies examining childhood-onset T1DM cannot 
necessarily be applied to cases of T1DM diagnosed after the age of 15. Possible 
environmental risk factors for T1DM should also be studied in patients 
diagnosed in young adulthood, as these may be different than in childhood-onset 
cases.   
 
• Possibilities of applying the increasing knowledge of the associations of fetal and 
childhood development on the risk for T2DM to primary prevention should be 
examined. 
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Appendix 1. ICD-9 and ICD-10 codes relevant for the study 
 
  ICD-9   ICD-10   
2500B Insulin-dependent diabetes 
no complications  
E10.9 Type 1 diabetes no 
complications 
2501B-
2508B 
Insulin-dependent diabetes 
with complications 
E10.0-
E10.8 
Type 1 diabetes with 
complications 
T1DM 
    O24.0 Insulin-treated diabetes 
diagnosed before 
pregnancy 
2500A Non insulin-dependent 
diabetes no complications 
E11.9 Type 2 diabetes no 
complications 
2501A-
2508A 
Non insulin-dependent 
diabetes with complications 
E11.0- 
E11.8 
Type 2 diabetes with 
complications 
T2DM  
    O24.1 Non insulin-treated 
diabetes diagnosed 
before pregnancy 
DM 2500C Maturity-onset diabetes of 
the youth 
E13 Other diabetes 
2500X Non specified diabetes E14 Non specified diabetes 
    E12 Diabetes related to 
malnutrition 
G59.0 Diabetic 
mononeuropathy 
G62.2 Diabetic polyneuropathy 
G99.0 Autonomic neuropathy 
    
G73.0 Diabetic amyotrophy 
H28.0 Diabetic cataract     
H36.0 Diabetic retinopathy 
    I79.2 Peripheric angiopathy 
    M14.6 Neuropathic arthropathy 
  
    N08.3 Diabetic nephropathy 
     
 
DM     O24.2 Malnutrition-related 
diabetes before 
pregnancy 
      O24.3 Non specific diabetes 
before pregnancy 
      P70 Transient disorders of 
carbohydrate 
metabolism in newborn 
      R73 Hyperglycemia 
GDM 6480A Gestational diabetes O24.4 Gestational diabetes 
  6488A Abnormal glucose tolerance 
during pregnancy 
O24.9 Non specified diabetes 
during pregnancy 
Secondary  5770 Acute pancreatitis  K85 Acute pancreatitis 
DM 5771 Chronic pancreatitis  K86 Acute and chronic 
pancreatitis caused by 
consumption of alcohol 
  5779 Non-specified disease of the 
pancreas 
K86.3 
Non-specified disease of 
the pancreas 
      K87.1 Disease of the pancreas 
related to other disease 
      K90.3 Pancreatic steatorrhea  
  0723A Pancreatitis caused by 
mumps 
B26.3 Pancreatitis caused by 
mumps 
  157 Cancer of the pancreas C25 Cancer of the pancreas 
  2530A Acromegaly E22.0 Acromegaly 
  2550A Cushing’s syndrome E24 Cushing’s syndrome 
      E31.00 APECED syndrome 
  2750 Hemochromatosis E83.1 Disorders of iron 
metabolism 
  2751 Wilson’s disease E83.0 Disorders of copper 
metabolism 
  2770A Cystic fibrosis E84 Cystic fibrosis 
  
  
5710- 
5713 
Alcoholic liver disease K70 Alcoholic liver disease 
  
   
 
Secondary 7517A Malformation of the 
pancreas 
Q45.0-
Q45.3 
Malformation of the 
pancreas 
DM 7580A Down’s syndrome Q90 Down’s syndrome 
  8680A Lesion of abdominal organ 
(other than gastro-intestinal 
tract, liver, spleen or 
kidney) 
S36.2 Lesion of the pancreas 
  2513A Postoperative 
hypoinsulinemia 
E89.1 Iatrogenic 
hypoinsulinemia 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
